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1. INTRODUCTION 
An individual skeletal muscle is comprised of numerous fascicles of 
skeletal muscle fibres. Each individual skeletal muscle fibre is innervated by a 
single nerve terminal, the axon of which originates from alpha motor neurons in 
the anterior horn of the spinal cord (Figure 1) (1). An efferent motor axon along 
with the muscle fibres supplied by its branches comprises a motor unit (2). The 
point of contact between a motor axon and a muscle fibre is called 
neuromuscular junction. In 98% cases, muscle fibres have only one such junction 
per muscle fibre (1).  
Spasticity is defined as a motor disorder characterized by an increase in 
muscle tone. It is associated with exaggerated tendon reflexes, resulting from 
hyper excitability of the stretch reflex, and is seen as one of the components of 
upper motor neuron syndrome. Spasticity may accompany diffuse or localized 
cerebral or spinal pathology (3). It is seen in conditions like stroke, traumatic 
brain injury, spinal cord injury, cerebral palsy, multiple sclerosis and other 
neurological disorders of central nervous system (4).  
Complications of Spasticity 
 Interferes with activities of daily living  
 Causes extreme pain/ discomfort in patients 
 Disfigurement 
 Increased risk for development of decubitus ulcer 
 Interferes with nursing care 
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 Interferes with hygiene 
 Development of muscle contractures 
 May cause bone fractures 
 Joint subluxation/dislocation 
 Increased risk of heterotopic ossification 
 Acquired peripheral neuropathy 
The treatment modalities for spasticity include a) Supportive treatment 
such as splints, b) Physical modalities like application of cold or heat therapy, c) 
Pharmacological modalities and d) Surgical treatment (5). The latter two are the 
most commonly used modalities of treatment. The pharmacologic agents can be 
administered through enteric route, transdermal route, intrathecal and local 
injections directly into the affected muscle. Direct intramuscular injections are 
the best choice for treating focal spasticity with minimum systemic side-effects 
(5). Most commonly used enteral and transdermal pharmacologic agents are 
Benzodiazepenes, Baclofen, Dantrolene sodium, Clonidine and Tizanidine.  
When the spasticity is focal and segmental such as affecting a single 
muscle group or limb, they can be treated by chemical neurolysis or chemical 
denervation. Chemical denervation is a type of nerve block, where the neural 
tissue is destroyed by chemical agents to give a long lasting effect. Motor-point 
block is a type of chemical denervation. Motor-point block involves blocking the 
motor component of a nerve close to the neurovascular hilus of a muscle, thereby 
avoiding sensory adverse effects (5). The agents commonly used in chemo-
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denervation are phenol, ethanol and botulinum toxin. The action of phenol and 
ethanol are due to their ability to denature protein. It is a crude process and 
affects both motor and sensory nerve fibers (5). Phenol in low concentrations is 
known to cause reversible local anaesthesia. Alcohol has a dehydrating effect on 
nerve tissues and cause sclerosis of nerve fibres and myelin sheath. These agents 
are injected at motor entry points. The complications of using phenol and alcohol 
for chemo-denervation include pain, dysesthesia and arrhythmias (3). 
 Botulinum toxin inhibits the release of acetylcholine at the neuromuscular 
junction and is an extremely potent neuromuscular blocking agent when injected 
at the motor entry point (5). This results in effective chemical denervation of 
muscle fibres, preventing muscle contraction, causing significant relief of 
spasticity (3). The advantage of botulinum toxin is that it acts selectively on 
motor nerves without affecting sensory nerves (6). Studies on chemo-denervation 
using botulinum toxin A has shown significant reduction in muscle tone and 
improved range of motion (5). 
Botox is available as a frozen lyophilized form of purified botulinum 
toxin A. It needs to be reconstituted with preservative-free saline before use, and 
should be used within 4 hours of reconstitution. Maximum therapeutic dose of 
Botox in adults is 400 units (5). The effect of Botox is dose-dependent i.e. the 
greater the toxin load, the higher the degree of relief from spasticity. When 
injected in higher doses Botulinum toxin has more chance of diffusing to 
surrounding muscles causing weakness of surrounding muscles. So, injections of 
lower doses of Botox aimed precisely at or close to the motor entry point, would 
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be ideal for optimum effect in decreasing spasticity with minimal systemic or 
regional side-effects (4). 
Neurotomy is performed in cases of localized disabling spasticity without 
musculotendinous shortening, that are resistant to chemical denervation and for 
which a motor nerve block with local anaesthesia has given a good functional 
result. Neurotomy includes division of the afferent Ia and Ib fibers, which are 
unable to recover, leading to permanent disappearance of the spasticity. 
Neurotomy also includes sectioning of the motor efferent fibers which results in 
transient paresis. In adults, neurotomy provides functional improvement in 81% 
to 97% of cases (7). In the lower limb, obturator neurotomy is indicated for 
spasticity of the adductor muscles, hamstring neurotomy for spastic knee flexion 
deformity and tibial neurotomy for the spastic foot deformity. Anterior tibial 
neurotomy is indicated for the extensor hallucis spasticity and femoral 
neurotomy for spasticity of quadriceps. In the upper limb, neurotomy of the 
nerves supplying pectoralis major and teres major is indicated for spasticity of 
internal rotators of shoulder. Neurotomy of musculocutaneous, median and ulnar 
nerves are performed for elbow flexion deformity, spasticity of pronators and  
wrist and finger flexors (8). Selective motor fasciculotomy, is a novel procedure 
of dividing the motor nerve at the point where it enters the muscle (motor entry 
point) (9). It is a surgical procedure which involves selective sectioning of motor 
nerves innervating the spastic muscles. 
Most common muscle groups involved in spasticity following 
cerebrovascular accidents, cerebral palsy and spinal injuries are the adductor and 
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hamstring groups of lower limb. This study was done to localize the motor entry 
points of adductor and hamstring muscles of lower limb, suggest ideal sites for 
intramuscular injection of pharmacologic agents in chemical neurolysis, and 
precisely localize motor entry points for fasciculotomy. This study would be 
beneficial for clinicians treating conditions of lower limb spasticity. This study is 
also the first of its type in the Indian population. 
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2. AIMS 
The aims of the study were: 
a. To determine the motor entry points of hamstring and adductor group of 
muscles of thigh 
b. To suggest ideal sites for invasive interventional procedures such as motor 
point injection of chemical neurolytic agents and selective motor 
fasciculotomy for relief of muscle spasticity in neuromuscular disorders 
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3. OBJECTIVES 
The objectives of our study include: 
a. To identify the motor entry points of Hamstring muscles- long head of 
Biceps femoris, Semitendinosus and Semimembranosus 
b. To identify the motor entry points of Adductor muscles of thigh – 
Adductor longus, Adductor magnus and Gracilis 
c. To localize the proximal motor entry point of the nerve to the above 
muscles 
d. To localize the distal motor entry point of the nerve to the above muscles 
e. To identify the portion or segment of the muscle that has the highest 
concentration of motor entry points per unit area 
f. To describe the proximal motor entry point as X and Y- co-ordinates 
using reference axes in the hamstring group 
g. To describe the distal motor entry point as X and Y- co-ordinates using 
reference axes in the hamstring group 
h. To assess correlation between length of the muscle and number of motor 
entry points  
i. To assess correlation between length of the muscle and position of 
proximal and distal motor entry points 
j. To assess correlation between length of the muscle and distance between 
proximal and distal motor entry points 
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k. To describe the optimum site of invasive interventional procedures such 
as i) motor point injection of chemical neurolytic agents and ii) selective 
motor fasciculotomy for relief of muscle spasticity in neuromuscular 
disorders 
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4. REVIEW OF LITERATURE 
4.1. Introduction  
An individual skeletal muscle fibre is supplied by a single axon, which 
originates from large alpha motor neurons in the anterior horn of the spinal cord 
(Figure 1)(1). An efferent motor axon with the muscle fibres supplied by its 
branches comprise a motor unit (2). This was first described by Sherrington in 
1925 (10). Each axon loses its myelin sheath before it enters the muscle, 
thereafter it is covered only by a thin portion of the neurilemmal Schwann cell 
(11). Each axon branches extensively into a number of terminal branches, before 
making actual contact with muscle fibres (12). The number of terminal branches 
depends on the precision of the motor control required by the muscle (13). 
4.2. Anatomy of neuromuscular junction 
The point of contact between a motor axon and a muscle fibre is called 
neuromuscular junction. In 98% of cases, muscle fibres have only one such 
junction per muscle fibre (1).  Each neuromuscular junction consists of axonal 
ending, its accompanying Schwann cell and motor end-plate (Figure 3 and 4) (2).  
The structure of a motor terminal varies with the type of muscle fiber 
innervated. In most types of muscles, the axonal ending is midway along a 
muscle fibre in a discoidal motor end plate called én plaque’ending. In some 
slow muscle fibres, the axon gives off numerous branches that form small 
expansions extending along the muscle fibre, so that, in the absence of 
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propagated muscle excitation, these excite the fibres at different points. The 
latter is also called én grappe’endings (14).   
4.21. Axon terminal at neuromuscular junction  
The axonal ending is a specialized terminal portion of a motor neuron 
which lacks neurofilaments and neurotubules. It has an abundance of vesicles 
and mitochondria (Figure 4). The axonal vesicles lie close to the axolemma (pre-
synaptic membrane) facing the muscle fibre. Pre-synaptic vesicles are about 60 
nm in diameter (13). It contains large amounts of neurotransmitter 
(acetylcholine) which is released into the synaptic cleft on stimulus. There is an 
abundance of mitochondria present in the axon terminal at the neuromuscular 
junction (1).  
4.22. Motor end plate  
The area of the muscle fibre upon which the branches of a single axon 
terminates is the motor end-plate (Figure 2). Electron microscopic examination 
of the motor end-plate reveals an abundance of sarcoplasm often rich in 
mitochondria forming the sole-plate (Figure 4)(2). The surface of the 
sarcolemma forms a shallow trough called the synaptic gutter or synaptic trough 
(1). The space between the axon terminal and the sarcolemma is called the 
synaptic space or cleft, which is 30-50 nm wide (13). At the bottom of the gutter, 
the sarcolemma is further folded to form numerous deeper secondary synaptic 
clefts or junctional folds (2), which greatly increase the surface area at which the 
synaptic transmitter can act (1). The junctional sarcoplasm contains 
11 
 
mitochondria, Golgi complex and ribosomes in association with rough 
endoplasmic reticulum and mitochondria. The junctional mitochondria are larger 
than those found in the terminal axoplasm and have abundant cristae (2). 
Mitochondria are the source of adenosine triphosphate (ATP), the energy source 
that is used for the synthesis of the excitatory neurotransmitter, acetylcholine (1). 
Microtubules are present in the junctional sarcoplasm which gives it structural 
integrity. The basal lamina of Schwann cells fuses with that of the muscle fibres 
at the primary synaptic cleft (2). Thus, a motor end plate is covered by one or 
more Schwann cells that insulate it from the surrounding environment (1). 
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4.3. Transmission of nerve impulse across neuromuscular junction 
Initiation and propagation of nerve impulses is the characteristic activity 
of a neuron. Excitation and contraction is the characteristic activity of muscle. 
The nerve impulses passing down the motor nerve brings about contractile 
response in the muscle, which is initiated by an intense depolarization of the 
muscle cell membrane (1).  
The neuromuscular transmission of the nerve impulse across the synaptic 
cleft is achieved by a chemical mediator and involves the following steps. First, 
the propagation of nerve impulse into the axon terminal of myo-neural junction; 
second, the release of a quantity of chemical transmitter from the axon terminals; 
third, diffusion of the neurotransmitter across the synaptic cleft to reach the 
underlying sarcolemma, and fourth, depolarization of the post synaptic 
membrane eventually resulting in muscle contraction (1).  
The most common neuro-transmitter in neuromuscular junctions is acetyl 
choline, which is formed by an enzymatic reaction at the axon terminal, mediated 
by choline-acetyl transferase. Acetyl –CoA is synthesized by mitochondria at the 
nerve terminal. Choline is obtained from outside the nerve terminal and 
transported into it across the membrane by an active process. Acetyl Co-A reacts 
with choline to form Acetylcholine (1). 
Vesicular packaging of the acetylcholine is important to protect it from 
the destruction by esterase which is also present in the axoplasm (2). Small 
vesicles which are about 40 nm in diameter are formed by the Golgi apparatus 
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present in the cell bodies of motor neurons in the spinal cord. These vesicles are 
transported through the axoplasm to the nerve terminals (1). The vesicle 
accumulates ACh from the surrounding axoplasm in the nerve terminal, the 
mechanism of which is not known (2). 
When a nerve impulse reaches the nerve terminal, the voltage-gated 
calcium channels on the pre-synaptic membrane open and allow the calcium ions 
from the synaptic space to enter into the nerve terminal. The calcium ions have 
the capacity to attract the acetylcholine vesicles towards the pre-synaptic 
membrane. The vesicles then fuse with the pre-synaptic membrane and discharge 
their contents into the synaptic cleft by exocytosis (1). The quanta of 
acetylcholine released is directly proportional to the calcium concentration and 
inversely proportional to the magnesium concentration (12). 
4.4. Mechanism of muscle contraction 
   In the postsynaptic muscle membrane, there are many nicotinic 
cholinergic acetylcholine receptors (12) which are acetylcholine-gated ion 
channels. These are located near the mouths of junctional folds. When the 
acetylcholine is attached to the receptor, the channel undergoes conformational 
changes and opens up. The channels are 0.65 nm in diameter, which allows the 
positive ions like sodium, potassium and calcium to move easily through the 
opening. The negative ions like chloride ions are however not allowed to pass 
through as they are repelled by strong negative charges in the mouth of the 
channel. The principle effect of opening the acetylcholine-gated channels is to 
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allow sodium ions to move inside the muscle fiber, creating an end-plate 
potential. The latter initiates an action potential which spreads across the muscle 
membrane. The action potential moves along T-tubules which further leads to 
release of calcium from the sarcoplasmic reticulum via ryanodine receptor. The 
released calcium binds to troponin-C, leading to conformational changes in 
tropomyosin. The latter results in exposure of binding sites on actin, to which 
myosin heads bind, bringing about muscle shortening (1). Simultaneously, the 
calcium ions are transported back into the terminal cisternae by the calcium-
activated ATPase pump in the membrane of sarcoplasmic reticulum. The resting 
concentration of calcium ions in the sarcoplasm is restored in less than 30 
milliseconds (11). 
In the synaptic space there are large quantities of the enzyme 
acetylcholinesterase that destroys acetylcholine, a few milliseconds after it is 
released from vesicles. A small amount of acetylcholine also diffuses out of the 
synaptic space and is no longer available to act on muscle fiber membrane. Thus 
the rapid removal of acetylcholine from the synaptic cleft prevents prolonged re-
excitation of the muscle fiber once it has recovered from its initial action 
potential (1).  
4.5. Spasticity  
Spasticity is defined as a motor disorder characterized by an increase in 
muscle tone. Spasticity is a velocity-dependent increase in muscle tone 
accompanied by exaggerated tendon reflexes. It results from hyper- excitability 
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of the stretch reflex and is a typical feature of an upper motor neuron syndrome. 
Spasticity may accompany diffuse or localized cerebral or spinal pathology (3). 
It is seen in conditions like cerebrovascular stroke, traumatic brain injury, spinal 
cord injury, spastic cerebral palsy, multiple sclerosis and other neurological 
disorders of the central nervous system (5).  
4.51. Pathophysiology of spasticity 
Spasticity is caused due to imbalance between excitatory and inhibitory 
supraspinal inputs to the spinal cord, leading to exaggerated stretch reflex (15). 
Spasticity can also be secondary to soft tissue changes like fibrosis and 
shortening of the paretic limb. The latter is also called non-reflex or intrinsic 
spasticity (16).  
The exaggeration of the stretch reflex in patients with spasticity would be 
caused by two factors. The first factor is an abnormal processing in the spinal 
cord of sensory inputs from muscle spindles, leading to an excessive reflex 
activation of   α-motor neurons. The second factor is an increased excitability of 
muscle spindles  (17).  
There are two major balancing descending systems controlling stretch 
reflex activity: the dorsal reticulospinal tract and the medial reticulospinal tract. 
The dorsal reticulospinal tract is inhibitory to extensor muscles and facilitatory to 
flexors. The medial reticulospinal and vestibulospinal tracts are facilitatory to 
extensor muscles and facilitatory to flexors (5). Only the ventromedial bulbar 
reticular formation, from which the dorsal reticulospinal tract takes origin, is 
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under cortical control. Brain lesions cause spasticity when they disrupt the 
facilitatory corticoreticular fibers, thus leading to the inhibition of the 
ventromedial reticular formation which gives origin to the dorsal reticulospinal 
tract. Incomplete spinal cord lesions cause spasticity when they destroy the 
dorsal reticulospinal tract which is inhibitory to extensors, sparing the medial 
reticulospinal tract which is facilitatory to extensors. In the complete spinal cord 
lesion, the facilitatory and inhibitory influences on the stretch reflex are lost (17).  
In the central nervous system lesions, hypersensitivity of receptors due to 
partial or complete denervation is documented. The resulting hyper-excitability 
of the postsynaptic membrane might be caused by the formation of new receptors 
or by morphological changes in denervated receptors. This phenomenon 
described as denervation hypersensitivity could be implicated in the increased 
excitability of α-motor neurons deprived of their regular descending excitation 
from the corticospinal pathways (17).  
After a UMN lesion, the α-motor neurons are known to release growth 
factors locally. These promote local sprouting from neighbouring interneurons, 
thus leading to the formation of new abnormal synapses between these 
interneurons and the somatic membrane of the deprived motor neurons. The new 
inter-neuronal endings branch onto the membrane of α-motor neurons, thus 
leading to the creation of new abnormal reflex pathways (17). 
Furthermore, the brainstem descending pathways like reticulospinal, 
vestibulospinal, tectospinal, and rubrospinal tracts are increasingly recruited to 
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take over some of the execution of motor command following disruption of the 
corticospinal pathways. The excitatory connections to spinal motor neurons of 
these pathways lead to muscle over-activity (17). 
Finally, an important mechanism could be the progressive reduction of 
post-activation depression due to limb immobilization (17). 
Spastic dystonia which is a common accompaniment of upper motor 
neuron lesions, is the tonic contraction of a muscle or a muscle group when an 
individual is at rest. It is a relative inability to relax muscles. Spastic dystonia can 
alter the resting posture of the individual, contributing to the hemiplegic posture: 
flexed and adducted upper limb and extended lower limb. It is sensitive to 
muscle stretch and length. It can be triggered by muscle stretch. But, prolonged 
stretch can reduce it. It is mediated by an abnormal pattern of supraspinal 
descending drive. Spastic dystonia is connected to the prolonged firing of α-
motor neurons (17). 
4.52. Complications due to spasticity (18) 
 Interferes with activities of daily living 
 Causes extreme pain/ discomfort in patients 
 Disfigurement 
 Increased risk for development of decubitus ulcer 
 Interferes with nursing care 
 Interferes with hygiene 
 Development of contractures 
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 May cause bone fractures 
 Joint subluxation/dislocation 
 Increased risk of heterotopic ossification 
 Acquired peripheral neuropathy 
Pain and Spasticity 
Spasticity may be the direct cause of pain. Lengthening a contracted 
muscle (eccentric contraction) can cause the disruption of some muscle fibers 
with the release of substances that may excite the muscle nociceptors. The same 
process is likely to happen when a spastic muscle is stretched. All the positive 
and negative features of upper motor neuron syndrome along with soft tissue 
changes disturbs body weight distribution, inducing excessive stress on joint 
structures and causing pain. Sensory disturbances also play a role. All these 
components contribute to the pain perceived by the patients with upper motor 
neuron syndrome. The relationship between spasticity and pain is made more 
strict by the fact that pain increases spasticity, creating a spiralling course of 
more pain and disability (17). 
4.53. Management of spasticity 
 The primary outcome parameter in the treatment of spasticity is 
optimizing function of the individual. Treatment decisions are made based on the 
functional limitations imposed by spasticity. Treatment goals can be divided into 
two categories. The first is management of passive function like reduction of 
pain, problems with position, hygiene, splint wearing and prevention of 
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contracture. Second is related to active functional activities, that is, 
accomplishing useful work within the diminished capacity of the patient (5). 
 The treatment modalities can be classified as supportive treatment, 
physical, pharmacological and surgical treatment. 
Supportive treatment 
 The conditions like pressure sores, contracture, deep venous thrombosis, 
sepsis and fracture should be addressed to reduce noxious stimulation since the 
latter might increase spasticity and muscle overactivity (5).  
 Proper positioning of the patient should be done by improving the body 
alignment and creating greater symmetry. It brings ease of nursing care, 
facilitation of therapy and maximization of a patient’s function (5). 
 Stretching the affected limb helps in preventing muscle shortening and 
increase in muscle sensitivity. Chronic stretch can be given using casts or splints 
(5). A regular exercise routine with daily range of motion exercise, helps to 
prevent loss of function (3). 
Physical modalities 
 Cooling of the muscles inhibits the monosynaptic stretch reflexes and 
lowers receptor sensitivity. Thus it is beneficial in the management of spasticity. 
Cooling is done either by applying ice or using evaporating spray such as ethyl 
chloride (5). 
20 
 
 Heat is another modality which helps in treatment of spasticity. It can be 
applied by different modalities like ultrasound, paraffin, fluidotherapy, 
superficial heat and whirlpool. Heat helps in increasing the elasticity of muscles. 
Heat application should be followed by stretching and exercise (5). 
 Electrical stimulation of nerves is a useful modality for spasticity due to 
central nervous system pathology. Electric stimulation by methods like 
transcutaneous electric nerve stimulator reduces pain by its nociceptive action 
and the resultant reduction in pain, and fatiguing the spastic muscles thereby 
activating antagonistic muscles through Ia interneurons (5). 
 Other physical modalities for decreasing spasticity include magnetic 
stimulation over thoracic spinal cord and topical application of 20% benzocaine 
(3).  
Pharmacologic treatment 
 The pharmacologic agents can be administered through enteric route, 
transdermal route, intrathecal and local injections. The last form of 
administration is the best choice for treating focal issues with minimum systemic 
effects (5). 
 Oral and transdermal medications are used in case of generalized muscle 
tone and spasms. They have the advantage of treating large areas of spasticity but 
have systemic side effects such as sedation. Benzodiazepines were the first 
agents used in the treatment of spasticity. They have a central action on 
brainstem reticular formation and spinal polysynaptic pathways. They act 
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through GABA-A, which opens membrane chloride channels, resulting in 
hyperpolarisation. Thus there is a reduction of monosynaptic and polysynaptic 
reflexes and an increase in presynaptic inhibition. Diazepam is the commonly 
used benzodiazepine.  
Baclofen acts through GABA-B and acts both presynaptically and 
postsynaptically. Acting presynaptically, it hyperpolarizes the membrane by 
preventing the influx of calcium and thus release of neurotransmitter. When it 
acts postsynaptically, it acts on the Ia afferents and hyperpolarizes the 
membrane.  
Dantrolene sodium inhibits calcium release from the sarcoplasmic 
reticulum during muscle contraction. It also reduces sensitivity of muscle spindle 
by acting on gamma motor neuron.  
Clonidine is centrally acting alpha-2-adrenergic agonist, which acts 
directly on locus coeruleus and decreases tonic facilitation and also enhances 
alpha-2 mediated presynaptic inhibition. Tizanidine is similar to clonidine but 
has a rapid onset of action (5).  
The US Food and Drug Administration has approved only baclofen, 
tizanidine, dantrolene sodium and diazepam for the treatment of spasticity (3). 
Clonazepam, Gabapentin, Vigabatrin, Topiramate, Lamotrigine, Riluzole, 
Cyproheptadine and Chlorpromazine are the other rarely used drugs for the 
management of spasticity (3). 
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Chemical neurolysis 
 
 When the symptoms of spasticity are focal and segmental, they can be 
treated by chemical neurolysis or chemical denervation. It is a method of treating 
upper motor neuron lesion and spasticity by creating a lower motor neuron 
lesion. Nerve block is the impairment of function of a nerve by application of a 
chemical. Chemical denervation is a type of nerve block, where the neural tissue 
is destroyed by chemical agents to give a long lasting effect. Motor-point block 
is further localized by blocking the distal portion of the nerve once all the 
sensory branches are given off, that is, blocking only the motor component of a 
nerve, causing minimal adverse effects (5). The local injectable therapy has the 
advantages of targeting a specific muscle and body region, prevention of 
contracture, reduction of pain associated with spasticity, improving the posture 
and reducing the need of splint (5). 
 The agents commonly used in chemo-denervation are phenol, ethanol and 
botulinum toxin. The action of phenol and ethanol are due to their ability to 
denature protein. It is a crude process and affects both motor and sensory fibers 
(5). Phenol in low concentrations also causes reversible local anaesthesia. 
Alcohol has a dehydrating effect on nerve tissues and cause sclerosis of nerve 
fibres and myelin sheath. These agents are injected at motor entry points. The 
complications of this procedure include pain, dysaesthesia and arrhythmias (3). 
 Botulinum toxin is isolated from Clostridium botulinum bacteria. It was 
first discovered by Van Ermengem in 1879. The neuromuscular blocking effect 
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of botulinum toxin was discovered in 1949. It was first used by Scott in 1973 for 
the treatment of strabismus (19). The toxin produced by bacteria can be 
classified into seven serotypes, A through G. Of the seven serotypes, most 
commonly used for treatment of spasticity are type A (Botox) and type B 
(Myobloc). The botulinum toxin inhibits the release of acetylcholine at the 
neuromuscular junction (Figure 5) (5) and is an extremely potent neuromuscular 
blocking agent when injected at the motor entry point. This results in effective 
chemical denervation of muscle fibres and failure of contraction (3). Botulinum 
toxin acts selectively on motor nerves without affecting sensory nerves (6). The 
chemo-denervation using botulinum toxin A has shown significant reduction in 
tone and improved the range of motion (5) and is approved by FDA for the 
treatment of strabismus, blepharospasm and facial dystonia (3). Myobloc was 
unable to show significant improvement in spasticity (5) and is approved by 
FDA for the treatment of cervical dystonia (3). 
Contraindications for the use of botulinum toxin are known sensitivity to 
botulinum, concurrent treatment with aminoglycoside antibiotics, myasthenia 
gravis, motor neuron disease and upper eyelid apraxia (18). 
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Botox is available as a frozen lyophilized form of purified botulinum toxin A. It 
need to be reconstituted with preservative-free saline before use, and should be 
used within 4 hours of reconstitution. Maximum therapeutic dose of Botox in 
adults is 400 units (5). The effect of Botox is dose-dependent. Greater the toxin 
load, the higher the degree of weakness. But higher doses have more chance of 
diffusing to surrounding muscles and cause weakness of surrounding muscles. 
So, a lower dose of Botox is to be injected precisely to the motor entry point, for 
optimum effect in decreasing spasticity with minimal side-effects (4). The initial 
effect of Botox injection is seen after 3 days, peaks at 3 weeks and duration of 
action of Botox is 3-4 months (18) after which the axons sprout new nerve 
terminal boutons (3). Botox injections have been shown to reduce the disability 
and improve the functional outcomes in patients (19). 
 Myobloc is available as a liquid preparation at a pH of 5.6 and does not 
need reconstitution. It has an inferior profile to Botox in the treatment of 
spasticity and has a superior side-effect profile (5). 
 The most common systemic side effects of botulinum toxin include 
unwanted weakness in adjacent muscles, dysphagia, nerve trauma, pain, antibody 
formation (18),  headache, flu-like symptoms, fatigue and nausea. Rare side 
effects are visual disturbances, dry mouth, ptosis, dysarthria and respiratory 
depression. Local side effects like pain and erythema at injection site are also 
seen. Treatment of limb spasticity might cause weakness of surrounding muscles. 
Injections for cervical dystonia might cause dysphagia and dysarthria (5). 
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 Intrathecal baclofen has a 100-fold increase in potency compared to oral 
medications (3) for the treatment of spasticity of cerebral and spinal origin. 
Screening for potential efficacy for intrathecal baclofen, is done by giving an 
intrathecal dose of baclofen by lumbar puncture. The screening is successful if 
there is substantial improvement in spasticity. Unsuccessful screening is 
followed by screening using double the dose of the first trial.  If the trial turns 
out to be successful, the patient is treated by giving double the dose of baclofen 
as was used for the successful screening, per 24 hours. The advantage of this 
type of therapy is that it delivers a continuous supply of baclofen through a 
catheter that is connected to the subarachnoid space. There is a reduced spasticity 
at a dose lower than that was used for oral administration. Problems with 
intrathecal baclofen therapy include high cost, infection risk, CSF leaks, pump 
dysfunction and kinking or disconnection of the catheter. Usually, the most 
cephalad placement of catheter is between T8 and T10 levels. Spasticity of upper 
limb and lower limb can be treated by inserting the catheter higher up till C4 
level (5). Other medications which are administered intrathecally are clonidine, 
midazolam, morphine, lidocaine and fentanyl. They are used singly or in 
combination with baclofen (5). 
Surgical procedures for the treatment of spasticity 
 The surgical procedures help in increasing mobility, decrease the use of 
external aids, prevent deformity and maximise function. The common 
orthopaedic procedures used for the treatment of spasticity include tendon 
lengthening surgery, muscle-tendon transfer, contracture release, resection 
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arthroplasty and osteotomy. The neuro-ablative  procedures done are 
neurectomy, neurotomy, rhizotomy, selective rhizotomy, dorsal root entry zone 
lesion and myelotomy (3). Selective dorsal rhizotomy, done by cutting off the 
affected sensory rootlets, leaving the motor system intact, is an effective 
procedure for the treatment of spasticity. It is usually followed by orthopaedic 
surgeries particularly soft tissue procedures (5).  
 Selective motor fasciculotomy 
The use of peripheral neurotomy was first described for the treatment of 
lower-limb spasticity by Lorenz
 
in 1887 to treat spastic hip adduction through 
obturator neurotomy. In 1912, Stoffel
 
first performed median nerve neurotomy 
for upper-limb spasticity initially by sectioning motor fascicles inside the trunk 
of the median nerve and later, at a more distal level, by dividing muscular 
branches to avoid sensory disturbances. Gros and colleagues
 
in 1976 
reintroduced selective peripheral neurotomy and refined the techniques by using 
neurosurgical advances in microsurgery and mapping through intraoperative 
electrical nerve stimulation (16). In 1988 Sindou and Mertens introduced testing 
methods with local anaesthetic agents and published long-term results on 
selective peripheral neurotomy of the tibial nerve for treating spastic foot.  
Brunelli and Brunelli
 
were the first to give details on the surgical techniques of 
selective peripheral neurotomy for the spastic upper limb. They did the 
neurotomy in two steps, six months apart, to treat any recurrence of spasticity 
(20). In a study done by Maarrawi et al., the neurotomy was done distally rather 
than proximally, to avoid injury to sensory fascicles (20). 
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Selective motor fasciculotomy, is the procedure of dividing the motor 
nerve at the point where it enters the muscle (motor entry point) (9). It is a 
neurosurgical procedure which involves partial sectioning of selected motor 
nerves innervating spastic muscles. Neurotomy is performed in cases of localised 
disabling spasticity without musculotendinous shortening, which is resistant to 
chemical denervation and for which a motor nerve block with anaesthetic has 
given a good functional result. Neurotomy includes division of the afferent Ia 
and Ib fibers, which are unable to recover, leading to permanent disappearance of 
the spasticity. Neurotomy also includes section of the motor efferent fibers with 
transient paresis as a result. In adults, neurotomy provides functional 
improvement in 81 to 97% of cases (7). 
In the lower limb, obturator neurotomy is indicated for spasticity of the 
adductor muscles, hamstring neurotomy for knee flexion deformity and tibial 
neurotomy for spastic foot deformity. Anterior tibial neurotomy is indicated for 
extensor hallucis spasticity and femoral neurotomy for spasticity in the 
quadriceps (18). Selective peripheral neurotomies were mostly performed for the 
treatment of lower-limb spasticity, with limited use for upper-limb spasticity due 
to the presence of more complex spastic deformities.  
Selective motor fasciculotomy for the treatment of spasticity, has been 
described for upper limb muscles (9, 21–23). In the upper limb, neurotomy of the 
nerves innervating pectoralis major and teres major is indicated for spasticity of 
the internal rotators of the shoulder. Neurotomy of musculocutaneous, median 
and ulnar nerves are performed for elbow flexion deformity, spasticity of 
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pronators and  wrist and finger flexors (8). In a study done by Sreekanth Reddy 
et al., selective motor fasciculotomy of musculocutaneous nerve, median and 
ulnar nerves resulted in decrease in spasticity of elbow flexors, pronators and 
radial wrist flexors and ulnar wrist flexors respectively. Therapeutic exercises are 
to be continued even after the surgery. The subjects who underwent surgery had 
no complications and recurrence of spasticity is also not reported yet (21). 
Selective motor fasciculotomy of the musculocutaneous nerve proved to be 
beneficial in spastic elbow in stroke patients (22, 24). In a study conducted by 
Pattisappu et al., fasciculotomy of median and musculocutaneous nerves resulted 
in much functional improvement in patients within 3 months of surgery, without 
any adverse effects like sensory disturbances (23).  Much improvement is seen in 
patients with long duration of spasticity and with contractures and deformities, 
when the fasciculotomy is followed by orthopaedic procedures (29).   
4.6. Clinical application of motor entry point 
  Phenol and alcohol are injected into the muscle at the motor entry point 
for the treatment of spasticity. Some authors also favour the injection of 
botulinum at the motor entry point (3). Selective motor fasciculotomy is also 
done at the motor entry point (9).  
  The motor entry points of hamstring muscles (25,26), adductors of thigh 
(27), tibialis posterior muscle (28–30), muscles of deep compartment of leg (30), 
triceps surae muscle (31,32), muscles of arm (33), antebrachial muscles (25), 
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flexor digitorum profundus (34) and thumb-in-palm muscles (35) have been 
reported.  
4.61. Spasticity of Hamstring muscles 
 
 The posterior femoral muscles are collectively termed the ‘hamstrings’. 
Hamstrings include Biceps femoris, Semitendinosus and Semimembranosus. 
They cause extension of the hip joint and flexion at the knee joint (13). 
 Hamstring spasticity is caused by over-activity of Biceps femoris, 
Semitendinosus and Semimembranosus muscles. It causes musculoskeletal 
complications and gait pattern deviations. It causes excessive flexion of the knee 
(36). The hamstring spasticity can be treated by blocking the branches of sciatic 
nerve supplying the muscle. The ideal point for blocking the sciatic nerve is at 
the level of ischial tuberosity. The disadvantage of this site is that it causes both 
sensory and motor nerve block. Pure motor block at the motor entry point will 
remove the sensory side effects of blocking the nerve (12). Hamstring spasticity 
can be alleviated by motor point injections, which can reduce the need for 
surgical procedures. Phenol and alcohol, though effective for 6 months, can 
cause adverse effects like dysaesthesia and local tissue necrosis. Botulinum toxin 
injection on the other hand, is relatively safe with a wide margin of safety.  
  
30 
 
Localization of motor entry points 
 
4.61.a. Long head of Biceps femoris 
 The long head of Biceps femoris arises from an inferomedial impression 
on the upper area of ischial tuberosity. It is inserted on the head of the fibula. It is 
supplied by the tibial division of sciatic nerve. The long head of Biceps femoris 
flexes the knee joint when it acts from above. It extends the hip joint when it acts 
from below. When the knee is semi-flexed or extended, the biceps femoris acts 
as a lateral rotator (13).  
Number of motor entry points 
In a study done by Seidel et al., (26) in 30 cadaveric lower limbs, 70 % of 
the long head of Biceps femoris had two motor entry points and 30 % had three 
motor entry points. A study done by Botter et al., (37) by electric stimulation 
with a surface electrode, revealed  the presence of two motor entry points for 
long head of Biceps femoris. 
Proximal and distal motor entry points 
In the study done by Seidel et al. in the U.S.A. (26), proximal entry point 
(PEP) was at 9.2 cm from the ischial tuberosity and distal entry point (DEP) was 
at 19.7 cm from the ischial tuberosity.  
In the study done by An et al.  (25), in the Korean population using 50 
lower limbs, the PEP and DEP were not described along the length of the 
muscle. It was described in relation to the X and Y-axis. The X-axis and Y-axis 
used in the study done by An et al. (25), was a line connecting ischial tuberosity 
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to greater trochanter and a line joining ischial tuberosity to the medial femoral 
condyle respectively.  
Optimal site for motor point injections in long head of Biceps femoris 
In his book on the treatment of spasticity with botulinum toxin, 
Fheodoroff describes the botulinum injection to be given at a point distal to 
proximal third of the line joining ischial tuberosity and medial end of popliteal 
fossa (38). The optimal injection for the long head of the biceps femoris 
described by Campenhout was an injection at 25% of the length of the thigh 
(measured from the superomedial aspect of ischial tuberosity to the medial 
femoral condyle) and one injection around 50%. 
4.61.b. Semitendinosus 
 The semitendinosus muscle arises from the inferomedial impression on 
the upper area of ischial tuberosity. It is inserted into the upper part of medial 
surface of tibia. It gets its nerve supply from the tibial division of sciatic nerve. 
The semitendinosus acts as a flexor of knee joint when it acts from above. It is an 
extensor of hip joint when it acts from below. It acts as a medial rotator when the 
knee is semi-flexed or extended (13). 
Number of motor entry points 
Study done by Botter et al., (37) by electric stimulation with a surface 
electrode, revealed the presence of one motor entry point for Semitendinosus 
muscle. In the study done by Seidel et al., (26) in 30 cadaveric lower limbs in the 
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U.S.A., in 77% of specimens the Semitendinosus had two motor entry points 
while 23% had one motor entry point. 
Proximal and distal entry points 
In the study done by Seidel et al., PEP was at 9 cm from the ischial 
tuberosity and DEP at 19 cm from the ischial tuberosity (26). According to 
Woodley et al., the PEP of Semitendinosus was at a distance of 4.2-12.2cm from 
the ischial tuberosity and the DEP was at a distance of 7.5-19cm from the ischial 
tuberosity (39). The X-axis and Y-axis used in the study done by An et al. (25) to 
describe PEP and DEP, was a line connecting ischial tuberosity to greater 
trochanter and a line joining ischial tuberosity to the medial femoral condyle 
respectively.  
 An et al. (25) divided the Semitendinosus into two zones: upper and 
lower. Upper zone was located where the proximal motor nerve branches entered 
the muscle and lower zone, where the distal motor nerve branches entered the 
muscle. In cases where the Semitendinosus muscle had only one motor nerve, the 
latter divideed into two branches before entering the muscle. The point of entry 
of the first branch was the upper zone and the point of entry of the second branch 
the lower zone.  
Optimal site for motor point injections in Semitendinosus 
In his book on the injection of botulinum toxin Fhedoroff describes the 
ideal point of motor point injection to be at the middle or distal third of the line 
joining ischial tuberosity to pes anserinus (38). In his book on the treatment of 
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spasticity, Berweck et al., describes the ideal point of botulinum toxin injection 
as halfway or two-third up the thigh (40). According to Campenhout (41), the 
PEP is located between 4.2 and 12.2 cm from the ischial tuberosity and the DEP 
is located between 7.5cm and 19 cm from the ischial tuberosity. Campenhout 
described the optimal site of motor point injection of Semitendinosus muscle as 
21% - 50% of the femur length, along a line joining ischial tuberosity to lateral 
femoral condyle. 
4.61.c Semimembranosus 
 The semimembranosus muscle arises from the superolateral impression on 
the ischial tuberosity. It is inserted into the tubercle on the posterior aspect of the 
medial tibial condyle (tuberculum tendinis). It gets its nerve supply from the 
tibial division of sciatic nerve. The semimembranosus acts as a flexor of knee 
joint when it acts from above. It is an extensor of hip joint when it acts from 
below. It acts as a medial rotator when the knee is semi-flexed or extended (6). 
Number of motor entry points  
  The study done by An et al., in Korea, showed the presence of a single 
motor nerve for Semimembranosus muscle. Though it had only one motor nerve, 
it divided into 2-5 branches (average=3.4) before entering the muscle. That is, 
the motor entry points ranged from 2-5 in number (25). A study done by Botter 
et al., by electric stimulation with a surface electrode, revealed the presence of 
one motor entry point for Semimembranosus muscle (37). In a study done by 
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Seidel et al., 47 % of Semimembranosus muscles had five motor entry points, 
20% had six motor entry points and 33% had 3-4 motor points (26).  
Proximal and distal motor entry points 
The motor points were described as percentage of length of femur in the 
study done by Seidel et al. In the same study, 50% of MEPs of 
Semimembranosus were located at 25-30 cm from the ischial tuberosity along a 
line drawn to medial femoral condyle (26). According to the study done by 
Campenhout (41), PEP of the Semimembranosus muscle can be located at 14.6 
to 21.2 cm distal to the ischial tuberosity. The DEP of the muscle was at 34.5cm 
distal to the tuberosity. According to Woodley et al., the PEPs to 
Semimembranosus muscle are located at 14.6 – 21.2 cm from the ischial 
tuberosity and DEPs are located at 34.5 cm distal to ischial tuberosity (39). The 
DEPs of Semimembranosus muscle are more distal than Semitendinosus muscle 
(41).  
The X-axis and Y-axis to localize the motor entry points used in the study 
done by An et al. (25), was a line connecting ischial tuberosity to greater 
trochanter and a line joining ischial tuberosity to the medial femoral condyle 
respectively.  
Optimal site for motor point injections in Semimembranosus 
The optimal injection site for the semimembranosus muscle described by 
Campenhout is between 64% and 77% of the femur length along a reference line 
from the ischial tuberosity to lateral femoral condyle. In the two textbooks by 
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Fheodoroff and Berwick, the sites of injection to Semimembranosus muscle are 
described as medial or lateral to Semitendinosus, at the limit of middle and distal 
third of the thigh, or half-way or two-thirds up the thigh (38,40). 
4.62. Spasticity of Adductor muscles of thigh 
 Muscles of the medial or adductor compartment of the thigh are 
collectively called the adductors of thigh. The latter include Gracilis, Pectineus, 
Adductor longus, Adductor brevis and Adductor magnus (13). 
Spasticity of adductor muscles of lower limb are a common 
accompaniment in neurological disorders like traumatic brain injury. It can cause 
difficulty in positioning, sitting, dressing and personal hygiene. It can also lead 
to hip subluxation leading to hip dislocation. It is effectively treated by surgical 
procedures like obturator neurectomy, selective dorsal neurectomy and 
orthopaedic procedures. But for candidates who are unfit for surgery, motor 
point injections with phenol and alcohol are effective. But, Botox overcomes the 
adverse effects (pain and paraesthesia) of the latter, and is relatively safe.  
One of the new methods to do obturator nerve block for the treatment of 
adductor spasticity is inter-adductor approach, where the needle is directed 
behind the upper end of Adductor longus muscle laterally and slightly upward 
with a posterior incination, towards the obturator canal (42). Novel methods 
using fluoroscopy and nerve stimulator are used to localise motor entry point in 
muscles (43).  
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Localization of motor entry points 
4.62.a. Adductor longus 
Number of motor entry points 
There is scarcity of data regarding the number of motor entry points of 
adductor muscles of thigh. 
Proximal and distal motor entry points 
According to the study done by Sung-Yoon Won et al, obturator nerve in 
Adductor longus spreads over a distance between 17.4% and 76.5% along the 
length of the nerve. He also describes the region of maximum density of 
neuromuscular junction in adductor longus muscle at 35-50% from anterior 
superior iliac spine and 20-40% from adductor tubercle (8). 
In a study done by Kwon et al (34), the motor entry points of Adductor longus 
muscle of thigh was located at 26 ± 4.8 % along a longitudinal axis drawn from 
the pubic tubercle to medial femoral condyle. In a study done by Crystal et al 
(35), the mean motor points of the Adductor longus muscle was described at 
31±1.1 %  along a reference line from the symphysis pubis to the medial joint 
line at the distal extent of the medial femoral condyle.  
Optimal site for motor point injections in Adductor longus 
The ideal injection points described by Fheodoroff and Berwick for 
Adductor longus muscle was in proximal third of the thigh (32,33). According to 
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Campenhout et al., the optimum point for motor point injections is distal to 31% 
of the reference line joining pubic tubercle to the medial femoral condyle. 
4.62.b. Adductor magnus 
Number of motor entry points 
There is scarcity of data regarding the number of motor entry points of 
adductor muscles of thigh. 
Proximal and distal motor entry points 
In a study done by Kwon et al (34), the motor entry points of Adductor 
magnus muscle of  thigh was located at 30.4 ± 4.1 % along a longitudinal axis 
drawn from the pubic tubercle to medial femoral condyle. In a study done by 
Crystal et al (35), The mean motor points of Adductor magnus were described at 
a point 38 ± 2.5 % of a reference line from the symphysis pubis to the medial 
joint line at the distal extent of the medial femoral condyle.  
Optimal site for motor point injections in Adductor magnus 
 The ideal injection point of botulinum toxin as described by Fheodoroff 
and Berwick for Adductor magnus is in a side-lying position, anterior and 
posterior to Gracilis in middle third of the thigh (32,33). According Campenhout 
et al (31), the ideal site of injection to Adductor magnus was distal to 38 % of the 
reference line joining pubic tubercle to the medial femoral condyle. This was at 
the middle third of the thigh. 
  
38 
 
4.62.c. Gracilis 
Number of motor entry points 
There is scarcity of data regarding the number of motor entry points of 
adductor muscles of thigh. 
Proximal and distal motor entry points 
 According to the study done by Sung-Yoon Won et al, obturator nerve in  
Gracilis muscle, spreads over 17.8% to 86% of the length of the muscle. The 
region with maximum density of neuromuscular junctions was found to be at 
29.2-33.5% along the length of Gracilis muscle by Yoon Won et al. This was 
located 40-50% from the anterior superior iliac spine and 25-35% from the pubic 
tubercle respectively (8). In a study done by Kwon et al (34), the motor entry 
points of Gracilis muscle of thigh was located at a point 32.1 ± 2.1 % along a 
longitudinal axis drawn from the pubic tubercle to medial femoral condyle. In a 
study done by Crystal et al (35), The mean motor points of Gracilis muscle were 
described at 44 ± 3.1 % of a reference line from the symphysis pubis to the 
medial joint line at the distal extent of the medial femoral condyle. 
Optimal sites for motor point injections in Gracilis muscle 
 Fheodoroff suggested the ideal point of botulinum toxin injection for 
Gracilis to be at middle third of a line joining pubic symphysis and pes anserinus 
(32). Berwick suggested the ideal point at the proximal third of the line joining 
pubic symphysis and pes anserinus (33).According to review article by 
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Campenhout et al (31), the optimum point for injection of Gracilis muscle was at 
the limit of proximal and middle third, and middle and distal third  of the thigh. 
Purpose of this study 
Most common muscle groups involved in spasticity following 
cerebrovascular accidents, cerebral palsy and spinal injuries are the adductor and 
hamstring groups of lower limb. This study was done to localize the motor entry 
points of adductor and hamstring muscles of lower limb, suggest ideal sites for 
intramuscular injection of pharmacologic agents, and precisely localize motor 
entry points in fasciculotomy. This study would be beneficial for the clinicians 
treating conditions of lower limb spasticity. This study is also the first of its type 
in Indian population. 
     
  
40 
 
5. MATERIALS AND METHODS 
This study on ‘Anatomical localization of motor entry points in muscles 
of lower limb commonly involved in spasticity’ was done after approval from the 
Institutional Review Board (IRB) and Research Ethics Committee.  
5.1. Sample size estimation 
Sample size estimation for the study was calculated by the following method 
(Table 1): 
Table 1: Sample size calculation 
Single Mean - Estimating the population mean - 
Absolute precision 
Standard Deviation  1.65 1.65 
Absolute Precision 1 1.5 
Desired confidence level (%) 95 95 
Required sample size 10 5 
 
Based on the range of data reported by Woodley and Mercer (2005), the mean 
and standard deviation was estimated to be 17.9 ±1.65 cm. In order to estimate 
this with the precision of 1 unit, we need to study 10 lower limbs. If the precision 
is 1.5 units then the number of lower limbs needed is 5.  
41 
 
 A total of 10 lower limbs from 5 formalin embalmed adult cadavers (4 
male and 1 female) aged between 33 to 92 years of age available in the 
department of Anatomy, Christian Medical College, Vellore were chosen for the 
study. Lower limbs having gross malformation, flexion deformities or severe 
injuries were excluded from the study. 
 All measurements were carefully standardised by the co-investigators 
which included a rehabilitative surgeon. A pilot study was done to assess 
feasibility. All variables were measured by one observer while the other observer 
recorded the results. Variables were measured using a Sliding Digital Vernier 
Calliper (ROBUST, Germany), with a resolution of 0.01mm, a measuring tape 
and a metre scale.  
5.2. Dissection  
The motor entry points of the following muscles were studied: a) 
Hamstring group – long head of Biceps femoris, Semitendinosus and 
Semimembranosus b) Adductor group of muscles of thigh – Adductor longus, 
Adductor magnus and Gracilis.  
With the cadaver in prone position, and the hip, knee and ankle joint in 
normal anatomical position, a midline longitudinal incision extending from the 
superolateral aspect of ischial tuberosity to the middle of the calf was made 
along the long axis of the lower limb. The proximal and distal ends of this 
incision were extended horizontally till the borders of the limb. After reflecting 
the skin, subcutaneous tissue and deep fascia, the hamstring muscles (long head 
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of Biceps femoris, Semitendinosus and Semimembranosus) were carefully 
exposed. The soft tissues over the ischial tuberosity, medial aspect of proximal 
tibia and head of fibula were removed to expose clearly the origins and insertions 
of the above muscles (Figure 7).  
The cadaver was then turned to a supine position and adductor group of 
muscles were exposed in the following sequence: Adductor longus, adductor 
component of Adductor magnus and Gracilis. The soft tissues overlying the 
origin and insertion of the muscles were carefully dissected to expose the 
attachment of tendons.  
5.3. Motor entry point 
All muscles were supplied by motor nerves from its deeper aspect. Under 
suitable lighting, the nerve branches to each muscle was carefully identified and 
dissected up to its motor entry point (Figure 9,14). No further dissection of the 
intramuscular course of the terminal nerve branches was done.  
The points of entry of each nerve branch to each muscle, the motor entry point 
(MEP) was identified (Figure 6). The point where the first branch of the nerve to 
the muscle pierced the muscle was described as proximal entry point (PEP) 
(Figure 6). The point of the muscle where the last branch of the nerve to the 
muscle pierced the muscle is called distal entry point (DEP) (Figure 6). The 
position of proximal and distal entry points were marked using colored pins to 
make accurate measurements (Figure 10,15). The distance of both the PEP and 
DEP from the origin of the muscle was measured using a measuring tape. 
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 5.4. Measurement of variables 
The variables measured were:  
a) The length of the muscle (L) - The length of each muscle from its 
origin to insertion was measured using a measuring tape (Figure 8). 
b) Number of motor entry points for each muscle (MEP) 
c) The distance of the proximal entry point (PEP) from the origin of the 
muscle – D(o-pep) 
d) The distance of the distal entry point (DEP) from the origin of the 
muscle – D(o-dep)  
e) The position of PEP and DEP as a fraction of the length of the muscle 
along its long axis was calculated and expressed as a percentage. It 
was calculated using the following formula:  
PEP% = (PEP/L) x 100  
DEP% = (DEP/L) x 100  
f) The ideal site of motor entry point injection (DPEP-DEP) – The ideal site 
of motor entry point injection was defined as the region between PEP 
and DEP having the maximum concentration of motor entry points. 
Hence, a nerve block attempted in this region would cause maximum 
relief from spasticity. 
g) As described in (f), the ideal site of motor point injection was also 
expressed as a percentage (D%PEP-DEP). 
h) The position of PEP and DEP of hamstring muscles were also 
described in relation to X and Y axes.  
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For the Hamstring group - The X-axis was defined as the line passing 
through the joint line of the knee joint. The Y-axis was defined as the line 
dropped perpendicular to the X-axis from the superolateral aspect of ischial 
tuberosity (Figure 13). The limbs of a long arm goniometer were used to denote 
the two axes, with the goniometer fixed at an angle of ninety degrees. The 
position of PEP and DEP was located using the above two axes. The distance of 
PEP and DEP from y-axis (x-coordinate) and distance of PEP and DEP from x-
axis (y-coordinate) was measured using a sliding digital vernier caliper 
(ROBUST, Germany), with a resolution of 0.01mm. The values medial to Y-axis 
were taken as negative values and those lateral to Y-axis as positive values. 
5.5. Data analysis 
 The data was entered into an Excel worksheet (Microsoft Office Excel; version 
2010) and analysed using SPSS (SPSS for windows, Version 16.0, Chicago, SPSS Inc.). 
Preliminary analysis was done by producing the summary statistics such as mean, 
median, standard deviation for all continuous measurements which follow normal 
distribution. Other continuous variables which do not follow normal distribution were 
reported with median, range, interquartile range and with necessary percentiles.All the 
nominal and ordinal Variables were reported with frequencies and their 
percentages.Student t-test was used to test whether any two groups differed in their 
means significantly, with assumptions satisfied. When assumptions were not satisfied, 
we used non-parametric tests. Pearson Correlation Coefficient was used to find the 
relationship between any two quantitative variables whereas Spearman Rank correlation 
coefficient was used in the non-parametric cases.The level of significance considered 
for the statistical test was 5%. 
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6. RESULTS 
The motor entry points of the following muscles were studied:  
a) Hamstring group – long head of Biceps femoris, Semitendinosus and 
Semimembranosus  
b) Adductor group of muscles of thigh – Adductor longus, Adductor 
magnus and Gracilis. 
6.1 Biceps femoris muscle 
The results of the variables measured are tabulated in Table 2.  
Table 2: Variables measured for long head of Biceps femoris. 
 
 
 
 
 
 
 
 
 
Parameter Median 
(cm) 
Inter-quartile 
Range (IQR) 
(cm) 
Range (cm) 
Length 40 38.5 - 42.2 38 – 43 
Number of MEPs 3 2 – 4 2 – 4 
PEP from origin 15 10.8 - 19.4 9.4 – 25.1 
DEP from origin 20.7 19.2 - 24.2 16.5 – 27 
PEP x-coordinate 2.4 -3.5 - 4.6 -4.6 – 4.8 
PEP y-coordinate 20.8 17.8 - 23.3 13.5 – 26.5 
DEP x-coordinate 2.3 -3.8 - 4.5 -6 – 5.2 
DEP y-coordinate 13.7 11.4 - 19.4 9 – 22 
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Length of the long head of Biceps femoris 
The median length of long head of Biceps femoris muscle, was found out 
to be 40 cm (IQR= 38.5-42.2 cm). The minimum length of the long head of 
Biceps femoris obtained was 38 cm and maximum length was 43 cm. Since the 
sample size was less and there were out-liers in values, median was a better 
representation of the average than mean.  
Number of motor entry points 
The median value of the number of motor entry points of the long head of 
Biceps femoris was 3 (IQR = 2-4). The minimum number of motor entry points 
was observed to be 2 and maximum number was 3. 
Proximal and distal motor entry points 
 The point on the muscle were the first branch of the nerve enters the 
muscle is the proximal entry point (PEP). The median value of the distance of 
PEP from the origin of the long head of Biceps femoris was found out to be 15 
cm (IQR= 10.8 – 19.4 cm). The minimum distance of PEP from the origin of 
long head of Biceps femoris was 9.4 cm and maximum distance was 25.1cm.
  
The point of entry of the last branch of the nerve into the muscle is called 
distal entry point (DEP). The median value of the distance of DEP from the 
origin of the long head of Biceps femoris was 20.7 cm (IQR = 19.2 – 24.2), with 
a minimum distance of 16.5 cm and a maximum distance of 27 cm. 
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X and Y conjugates of PEP and DEP 
PEP and DEP were also described in relation to X-axis and Y-axis. X-axis was a 
horizontal line passing through the joint line of knee joint. Y-axis is a vertical 
line passing downwards from the superolateral aspect of ischial tuberosity, to 
meet the X-axis. PEP was located at a point which was 2.4 cm (IQR = -3.5 – 4.6) 
from Y-axis (X co-ordinate) and 20.8 cm (IQR = 17.8 – 23.3) from X-axis (Y co-
ordinate). The X co-ordinate of DEP was at 2.3 cm (IQR = -3.8 – 4.5) from Y-
axis and Y co-ordinate was located at 13.7 cm (IQR = 11.4 – 19.4) from X-axis. 
PEP% and DEP% 
The distance of PEP and DEP from the origin of the muscle expressed as 
percentage of the entire length of the muscle is tabulated in Table 3. 
Table 3: Distance of PEP and DEP from the origin of the muscle expressed 
as percentage of the entire length of the long head of Biceps femoris.  
Parameter Median (%) Inter-quartile range (%) Range (%) 
(PEP/L) x 100 35 27.9 – 48.3 22.3 – 63.5 
(DEP/L) x 100 51.3 47.6 – 58.2 39.2 – 68.4 
 
 The proximal entry points were located at 35 % (IQR = 27.9 – 48.3) of the 
muscle length, with a range of 22.3% to 63.5%. The distal entry points were 
located at 51.3 % (IQR = 47.6 – 58.2) of the muscle length, with a range of 
39.2% to 68.4%. 
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Ideal site of motor point injection (D%(PEP-DEP)) 
The part of the muscle with motor entry points is shown in Table 4. 
Table 4: The part of the long head of Biceps femoris with motor entry points 
 
 
 
 
All the motor entry points to a muscle are located between PEP and DEP. 
So, it can be concluded that all the motor entry points are localized within a 
distance of 15.3 % (IQR = 4.7 – 21) from the PEP of the long head of Biceps 
femoris, or within a distance of 6.5 cm (IQR = 1.9 – 8.8) from PEP of Long head 
of Biceps femoris. The ideal site for motor point injections in long head of 
Biceps femoris is in the second-fifth and third-fifth of muscle length from its 
origin to insertion. 
  
Parameter Median Inter-quartile 
range 
Range 
Distance between 
PEP & DEP ( cm) 
 
6.5 
 
1.9 – 8.8 
 
1.1 – 11 
 
PEP-DEP% 
 
15.3 
 
4.7 – 21 
 
2.7 – 28.8 
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6.2. Semitendinosus 
Variables measured for semitendinosus are given in Table 5. 
Table 5: The variables measured for Semitendinosus 
 
 
 
 
 
 
 
 
 
 
Length of Semitendinosus 
The median length of Semitendinosus muscle, was found out to be 41.3 
cm (IQR= 39 – 42.6 cm). The minimum length of the Semitendinosus obtained 
was 38 cm and maximum length was 45 cm. 
 
Parameter Median 
(cm) 
Inter-quartile 
Range (IQR) 
(cm) 
Range (cm) 
Length 41.3 39 – 42.6 38 – 45 
Number of MEPs 2 1.8 – 2.3 1 – 8 
PEP from origin 17.6 16.8 – 19.3 5.5 – 21.9 
DEP from origin 20.6 18.6 – 22.6 17.5 – 23.8 
PEP X co-ordinate 1.5 -1.4 – 2.7 -3 – 12 
PEP Y co-ordinate 17.5 15.2 – 22 12.3 – 26.8 
DEP X co-ordinate 0.2 -1.9 – 1.7 -3.1 – 3.8 
DEP Y co-ordinate 14.7 14.1 – 17.9 8.7 – 18.6 
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Number of motor entry points 
The median value of the number of motor entry points of the 
Semitendinosus was 2 (IQR = 1.8 – 2.3). The minimum number of motor entry 
points was observed to be 1 and maximum number was 8. 
Proximal and distal motor entry points 
 The point on the muscle were the first branch of the nerve enters the 
muscle is the proximal entry point (PEP). The median value of the distance of 
PEP from the origin of the Semitendinosus was found out to be 17.6 cm (IQR= 
16.8 – 19.3 cm). The minimum distance of PEP from the origin of 
Semitendinosus was 5.5 cm and maximum distance was 21.9 cm.  
The point of entry of the last branch of the nerve into the muscle is called 
distal entry point (DEP). The median value of the distance of DEP from the 
origin of the Semitendinosus muscle was 20.6 cm (IQR = 18.6 – 22.6), with a 
minimum distance of 17.5 cm and a maximum distance of 23.8 cm. 
X and Y conjugates of PEP and DEP 
 PEP and DEP were also described in relation to X-axis and Y-axis. X-axis 
was a horizontal line passing through the joint line of knee joint. Y-axis is a 
vertical line passing downwards from the superolateral aspect of ischial 
tuberosity, to meet the X-axis. PEP was located at a point which was 1.45 cm 
(IQR = -1.4 – 2.7) from Y-axis (X co-ordinate) and 17.5 cm (IQR = 15.2 – 22) 
from X-axis (Y co-ordinate). The X co-ordinate of DEP was at 0.2 cm (IQR = -
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1.9 – 1.7) from Y-axis and Y co-ordinate was located at 14.65 cm (IQR = 14.1 – 
17.9) from X-axis. 
PEP% and DEP% 
 The distance of PEP and DEP from the origin of the muscle expressed as 
percentage of the entire length of the muscle is tabulated in Table 6. 
Table 6: The distance of PEP and DEP from the origin of the muscle 
expressed as percentage of the entire length of the Semitendinosus. 
Parameter Median (%) Inter-quartile range (%) Range (%) 
(PEP/L) X 100 43.6 38.7 – 48.2 14.1 – 54.8 
(DEP/L) X 100 48.1 44.5 – 58.3 41.6 – 60.5 
 
The proximal entry points were located at 43.6 % (IQR = 38.7 – 48.2) of the 
muscle length, with  a range of 14.1 % to 54.8 %. The distal entry points were 
located at 48.1 % (IQR = 44.5 – 58.3) of the muscle length, with a range of 
41.6% to 60.5%. 
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The ideal site for motor point injections 
The part of the muscle containing the motor entry points are given in Table 7. 
  
Table 7: The part of the Semitendinosus with motor entry points 
 
 
 
 
 
All the motor entry points to a muscle are located between PEP and DEP. 
So, it can be concluded that all the motor entry points are localised within a 
distance of 4.8 % (IQR = 3.2 – 12.5) from the PEP of the Semitendinosus, or 
within a distance of 2 cm (IQR = 1.3 – 4.8) from PEP of Semitendinosus. The 
suggested site for the motor point procedures of Semitendinosus from our study 
is in the third-fifth of the muscle length from the origin of the muscle. 
 
  
Parameter Median Inter-quartile 
range 
Range 
Distance between 
PEP&DEP (cm) 
 
2 
 
1.3 – 4.8 
 
1.2 – 12 
 
PEP-DEP% 
 
4.8 
 
3.2 – 12.5 
 
2.7 – 30.8 
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6.3.Semimembranosus 
Variables measured for Semimembranosus are given in Table 8. 
Table 8:The variables measured for Semimembranosus 
 
 
 
 
 
 
 
 
 
 
Length of the muscle 
The median length of Semimembranosus muscle, was found out to 36 cm 
(IQR= 34.9 – 39.5 cm). The minimum length of the Semimembranosus obtained 
was 33 cm and maximum length was 41 cm. 
 
Parameter Median 
(cm) 
Inter-quartile 
Range (IQR) 
(cm) 
Range (cm) 
Length 36 34.9 – 39.5 33 – 41 
Number of MEP 3 2 – 4.3 2 – 7 
PEP from origin 19.9 17.4 – 23.9 15 – 26 
DEP from origin 25.3 23.5 – 27.5 23.2 – 29 
PEP X co-ordinate 0.5 -0.6 – 2.4 -2.4 – 4 
PEP Y co-ordinate 16.5 13.9 – 17.3 11.8 – 20.2 
DEP X co-ordinate 0.4 -0.2 – 2.5 -2.5 – 4.2 
DEP Y co-ordinate 10.6 8.8 – 12.4 7 – 14 
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Number of motor entry points 
The median value of the number of motor entry points of the 
Semimembranosus was 3 (IQR = 2 – 4.3). The minimum number of motor entry 
points was observed to be 2 and maximum number was 7. 
Proximal and distal entry points 
 The point on the muscle were the first branch of the nerve enters the 
muscle is the proximal entry point (PEP). The median value of the distance of 
PEP from the origin of the Semimembranosus was found out to be 19.85 cm 
(IQR= 17.4 – 23.9 cm). The minimum distance of PEP from the origin of 
Semimembranosus was 15 cm and maximum distance was 26 cm.  
The point of entry of the last branch of the nerve into the muscle is called 
distal entry point (DEP). The median value of the distance of DEP from the 
origin of the Semimembranosus was 25.3 cm (IQR = 23.5 – 27.5), with a 
minimum distance of 23.2 cm and a maximum distance of 29 cm. 
X and Y conjugates 
 PEP and DEP were also described in relation to X-axis and Y-axis. X-axis 
was a horizontal line passing through the joint line of knee joint. Y-axis is a 
vertical line passing downwards from the superolateral aspect of ischial 
tuberosity, to meet the X-axis. PEP was located at a point which was 0.5 cm 
(IQR = -0.6 – 2.4) from Y-axis (X co-ordinate) and 16.5 cm (IQR = 13.9 – 17.3) 
from X-axis (Y co-ordinate). The X co-ordinate of DEP was at 0.4 cm (IQR = -
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0.2 – 2.5) from Y-axis and Y co-ordinate was located at 10.6 cm (IQR = 8.8 – 
12.4) from X-axis. 
PEP% and DEP% 
 The distance of PEP and DEP from the origin of the muscle expressed as 
percentage of the entire length of the muscle is tabulated in Table 9. 
Table 9:The distance of PEP and DEP from the origin of the muscle 
expressed as percentage of the entire length of the Semimembranosus. 
Parameter Median (%) Inter-quartile range (%) Range (%) 
(PEP/L) X 100 52.5 45.2 – 65.8 43.9 -68.1 
(DEP/L) X 100 70.1 65.9 - 74.4 59.2 - 78.8 
 
The proximal entry points were located at 52.5 % (IQR = 45.2 – 65.8) of 
the muscle length, with a range of 43.9 % to 68.1 %. The distal entry points were 
located at 70.1 % (IQR = 65.9 – 74.4) of the muscle length, with a range of 
59.2% to 78.8%. 
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Ideal site of motor point injections 
The part of the muscle containing all the motor entry points is given in Table 10. 
Table 10:The part of the Semimembranosus containing the motor entry 
points 
 
 
 
 
All the motor entry points to a muscle are located between PEP and DEP. 
So, it can be concluded that all the motor entry points are localised within a 
distance of 10.4 % (IQR = 7.2 – 25.9) from the PEP of the Semimembranosus, or 
within a distance of 3.9 cm (IQR = 2.6 – 9.5) from PEP of Semimembranosus. 
So, we conclude that the ideal site of motor point injections on 
Semimembranosus is in the third-fifth and fourth-fifth of the muscle length from 
the origin of the muscle. 
 
  
Parameter 
Median 
Inter-quartile 
range 
Range 
Distance between 
PEP&DEP (cm) 
 
3.9     2.6 - 9.5 
       2.2 – 11 
PEP-DEP% 10.4 7.2 - 25.9 6.1 - 33.3 
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6.4.Adductor longus 
Variables measured for Adductor longus are given in Table 11. 
Table 11:The variables measured for Adductor longus 
 
 
 
 
 
 
 
 
 
 
Length of the muscle 
The median length of Adductor longus muscle, was found out to be 22 cm 
(IQR= 17 - 23 cm). The minimum length of the Adductor longus obtained was 
16 cm and maximum length was 25 cm. 
 
Parameter Median 
(cm) 
Inter-quartile 
Range (IQR) 
(cm) 
Range (cm) 
Length 22 17 – 23 16 – 25 
Number of MEP 2 2 – 3 2 – 8 
PEP from origin 8.8 4.8 – 9.6 4 – 10.8 
DEP from origin 9.6 9.5 – 11.5 8.8 – 14.2 
PEP X co-ordinate 7 5.7 – 8.1 3.2 – 10.4 
PEP Y co-ordinate 10.8 7.6 – 13.1 0.6 – 16.5 
DEP X co-ordinate 7.3 5.2 – 9.6 3.4 – 10.5 
DEP Y co-ordinate 13.2 9.6 – 15.5 1.6 – 20 
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Number of motor entry points 
The median value of the number of motor entry points of the Adductor 
longus was 2 (IQR = 2 - 3). The minimum number of motor entry points was 
observed to be 2 and maximum number was 8. 
Proximal and distal motor entry points 
 The point on the muscle where the first branch of the nerve enters the 
muscle is the proximal entry point (PEP). The median value of the distance of 
PEP from the origin of the Adductor longus was found out to be 8.8 cm (IQR= 
4.8 – 9.6 cm). The minimum distance of PEP from the origin of Adductor longus 
was 4 cm and maximum distance was 10.8 cm.  
The point of entry of the last branch of the nerve into the muscle is called 
distal entry point (DEP). The median value of the distance of DEP from the 
origin of the Adductor longus was 9.6 cm (IQR = 9.5 – 11.5), with a minimum 
distance of 8.8 cm and a maximum distance of 14.2 cm. 
X and Y conjugates of PEP and DEP 
 PEP and DEP were also described in relation to X-axis and Y-axis. X-axis 
was a line joining anterior superior iliac spine to the pubic tubercle. Y-axis is a 
line passing downwards from the pubic tubercle to the adductor tubercle. PEP 
was located at a point which was 7 cm (IQR = 5.7 – 8.1) from Y-axis (X co-
ordinate) and 10.8 cm (IQR = 7.6 – 13.1) from X-axis (Y co-ordinate). The X co-
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ordinate of DEP was at 7.3 cm (IQR = 5.2 – 9.6) from Y-axis and Y co-ordinate 
was located at 13.2 cm (IQR = 9.6 – 15.5) from X-axis. 
PEP% and DEP% 
The distance of PEP and DEP from the origin of the muscle expressed as a 
percentage of the entire length of muscle is given in Table 12. 
Table 12:The distance of PEP and DEP from the origin of the muscle 
expressed as percentage of the entire length of the Adductor longus. 
 
 
 
 
The proximal entry points were located at 39.3 % (IQR = 28.2 – 42.7) of the 
muscle length, with a range of 17.4 % to 45.7 %. The distal entry points were 
located at 49.3 % (IQR = 44.8 – 55.9) of the muscle length, with a range of 
41.7% to 61.7 %. 
 
 
 
 
 
 
 
Parameter Median (%) Inter-quartile range (%) Range (%) 
(PEP/L) X 100 39.3 28.2 – 42.7 17.4 – 45.7 
(DEP/L) X 100 49.3 44.8 - 55.9 41.7 - 61.7 
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Ideal site for motor point injections 
The part of the muscle containing the motor entry points is given in Table 13. 
 
Table 13:The part of Adductor longus containing the motor entry points 
 
All the motor entry points to a muscle are located between PEP and DEP. 
So, it can be concluded that all the motor entry points are localised within a 
distance of 10.7 % (IQR = 3 – 26.4) from the PEP of the Adductor longus, or 
within a distance of 2.5 cm (IQR = 0.7 – 4.4) from PEP of Adductor longus. The 
ideal site for motor point injections suggested from our study is in the third-fifth 
of the muscle length from the origin of the muscle. 
 
 
 
 
 
 
Parameter Median Inter-quartile 
range 
Range 
Distance between 
PEP&DEP (cm) 
 
2.5 0.7 – 4.4 0.3 – 8 
PEP-DEP% 10.7 3 - 26.4 1.3 - 34.8 
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6.5. Adductor magnus 
Variables measured for Adductor magnus are given in Table 14. 
Table 14:The variables measured for Adductor magnus 
 
Length of Adductor magnus 
The median length of Adductor magnus muscle, was found out to be 34 
cm (IQR= 32.9 – 35.4 cm). The minimum length of the Adductor longus 
obtained was 32.5 cm and maximum length was 38 cm. 
 
  
Parameter Median 
(cm) 
Inter-quartile Range 
(IQR) (cm) 
Range (cm) 
Length 34 32.9 - 35.4 32.5 – 38 
Number of MEP 1 1 - 3.2 1 – 8 
PEP from origin 10.5 9.5 – 13 5 - 14.5 
DEP from origin 13 6.3 – 15 6 – 15 
PEP X-coordinate 5.7 4.4 - 8 3.5 - 10.9 
PEP Y-coordinate 14.4 9.6 - 18.1 2 – 22 
DEP X-coordinate 12.5 5 - 15.5 5 - 15.5 
DEP Y-coordinate 5 3.5 - 14.5 4 – 14 
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Number of motor entry points 
The median value of the number of motor entry points of the Adductor 
longus was 1 (IQR = 1 - 3.2). The minimum number of motor entry points was 
observed to be 1 and maximum number was 8. 
Proximal and distal entry points 
 The point on the muscle were the first branch of nerve enters the muscle is 
the proximal entry point (PEP). The median value of the distance of PEP from 
the origin of the long head of Biceps femoris was found out to be 10.5 cm (IQR= 
9.5 – 13 cm). The minimum distance of PEP from the origin of Adductor longus 
was 5 cm and maximum distance was 14.5 cm.  
The point of entry of the last branch of nerve into the muscle is called 
distal entry point (DEP). The median value of the distance of DEP from the 
origin of the muscle was 13 cm (IQR = 6.3 – 15), with a minimum distance of 6 
cm and a maximum distance of 15 cm. 
X and Y conjugates of PEP and DEP 
 PEP and DEP were also described in relation to X-axis and Y-axis. X-axis 
was a line joining anterior superior iliac spine to the pubic tubercle. Y-axis is a 
line passing downwards from the pubic tubercle to the adductor tubercle. PEP 
was located at a point which was 5.7 cm (IQR = 4.4 – 8) from Y-axis (X co-
ordinate) and 14.35 cm (IQR = 9.6 – 18.1) from X-axis (Y co-ordinate). The X 
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co-ordinate of DEP was at 12.5 cm (IQR = 5 - 5.5) from Y-axis and Y co-
ordinate was located at 5 cm (IQR = 3.5 – 14.5) from X-axis. 
PEP% and DEP% 
The distance of PEP and DEP from the origin of the muscle expressed as a 
percentage of the entire length of the muscle is given in Table 15. 
Table 15:The distance of PEP and DEP from the origin of the muscle 
expressed as percentage of the entire length of Adductor magnus. 
 
Parameter Median (%) Inter-quartile range (%) Range (%) 
(PEP/L) X 100 31.2 28.3 – 38 15.4 – 42.1 
(DEP/L) X 100 38.2 19.4 - 41.1 19.4 - 41.1 
 
The proximal entry points were located at 31.2 % (IQR = 28.3 – 38) of the 
muscle length, with a range of 15.4 % to 42.1 %. The distal entry points were 
located at 38.2 % (IQR = 19.4 – 41.1) of the muscle length, with a range of 
19.4% to 41.1 %. 
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The ideal site for motor point injections 
The part of the muscle containing all the motor entry points is given in Table 16. 
Table 16:The part of the Adductor magnus containing the motor entry 
points. 
 
 
 
 
 
All the motor entry points to a muscle are located between PEP and DEP. 
So, it can be concluded that all the motor entry points are localised within a 
distance of 10.3 % (IQR = 4 – 12.3) from the PEP of the Adductor magnus 
within a distance of 3.5 cm (IQR = 1.3 – 4.5) from PEP of Adductor magnus. 
The ideal site for motor point injections in Adductor magnus is in the second-
fifth of the muscle length from the origin of the muscle. 
  
Parameter Median Inter-quartile 
range 
Range  
Distance between 
PEP&DEP (cm) 
 
3.5 1.3 – 4.5 1.3 – 4.5 
PEP-DEP% 
10.3 4 – 12.3 4 - 12.3 
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6.6.Gracilis 
Variables measured for gracilis is given in Table 17. 
Table 17: The variables measured for Gracilis 
 
 
 
 
 
 
 
 
 
 
Length of the muscle 
The median length of Gracilis muscle, was found out to be 41 cm (IQR= 
40 – 44.4 cm). The minimum length of the Gracilis obtained was 39 cm and 
maximum length was 44 cm. 
  
Parameter Median 
(cm) 
Inter-quartile 
Range (IQR) 
(cm) 
Range (cm) 
Length 41 40 – 44.4 39 – 44 
Number of MEP 6 3.8 – 8.2 3 – 16 
PEP from origin 12 10 – 13 5 – 15.6 
DEP from origin 15.5 14 – 16.6 14 – 18.3 
PEP X co-ordinate 4.2 3.4 – 8.4 2 – 9.5 
PEP Y co-ordinate 16.2 11.3 – 17.5 0.8 – 19 
DEP X co-ordinate 5.7 3.1 – 16.8 1 – 23 
DEP Y co-ordinate 18 13.8 – 20.3 0.9 – 21.5 
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Number of motor entry points 
The median value of the number of motor entry points of the Gracilis was 
6 (IQR = 3.8 – 8.2). The minimum number of motor entry points was observed to 
be 3 and maximum number was 16. 
Proximal and distal motor entry points 
 The point on the muscle were the first branch of the nerve enters the 
muscle is the proximal entry point (PEP). The median value of the distance of 
PEP from the origin of the Gracilis was found out to be 12.2 cm (IQR= 10 – 13 
cm). The minimum distance of PEP from the origin of Gracilis was 5 cm and 
maximum distance was 15.6 cm.  
The point of entry of the last branch of the nerve into the muscle is called 
distal entry point (DEP). The median value of the distance of DEP from the 
origin of the Gracilis was 15.5 cm (IQR = 14 – 16.6), with a minimum distance 
of 14 cm and a maximum distance of 18.3 cm. 
X and Y conjugates of PEP and DEP 
 PEP and DEP were also described in relation to X-axis and Y-axis.  X-
axis was a line joining anterior superior iliac spine to the pubic tubercle. Y-axis 
is a line passing downwards from the pubic tubercle to the adductor tubercle. 
PEP was located at a point which was 4.2 cm (IQR = 3.4 – 8.4) from Y-axis (X 
co-ordinate) and 16.2 cm (IQR = 11.3 – 17.5) from X-axis (Y co-ordinate). The 
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X co-ordinate of DEP was at 5.7 cm (IQR = 3.1 – 16.8) from Y-axis and Y co-
ordinate was located at 18 cm (IQR = 13.8 – 20.3) from X-axis. 
PEP% and DEP% 
The distance of PEP and DEP from the origin of the muscle expressed as 
percentage of the entire muscle is given in Table 18. 
Table 18: The distance of PEP and DEP from the origin of the muscle 
expressed as percentage of the entire length of the Gracilis. 
Parameter Median (%) Inter-quartile range (%) Range (%) 
(PEP/L) X 100 28.8 25.2 - 32.1 11.5 - 35.1 
(DEP/L) X 100 36.7 34.1 - 40.1 31.5 - 44.1 
 
The proximal entry points were located at 28.8 % (IQR = 25.2 – 32.1) of the 
muscle length, with a range of 11.5 % to 35.1 %. The distal entry points were 
located at 36.7 % (IQR = 34.1 – 40.1) of the muscle length, with a range of 
31.5% to 44.1 %. 
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The ideal site for motor point injections in Gracilis 
The part of the muscle containing all the motor entry points is given in Table 19. 
Table 19: The part of the Gracilis containing the motor entry points. 
 
 
 
 
All the motor entry points to a muscle are located between PEP and DEP. So, it 
can be concluded that all the motor entry points are localised within a distance of 
6.5 % (IQR = 2.6 – 15.5) from the PEP of Gracilis, or within a distance of 2.8 cm 
(IQR = 1.2 – 6.3) from PEP of Gracilis. The ideal site for motor point injections 
in Gracilis is in the second-fifth of its muscle length from the origin of the 
muscle. 
 
  
Parameter Median Inter-quartile 
range 
Range 
Distance between  
PEP & DEP (cm) 
 
2.8 1.2 – 6.3 0 – 12 
PEP-DEP% 6.5 2.6 - 15.5 0 - 27.6 
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6.7 Comparison between the length of the muscle and number of motor 
entry points. 
 The comparison between muscle length and number of motor entry 
points of all muscles done in this study shows a positive correlation between 
muscle length and number of motor entry points (Figure 16). The Pearson 
Correlation coefficient was 0.119 which shows only a weak positive correlation 
between the two parameters (Table 20).  
Figure 16: Scatter plot graph comparing the relation between length of the 
muscle and the number of motor entry points. 
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Table 20: Pearson correlation coefficient for the relationship between 
muscle length and number of MEPs  
  
 Muscle length MEP 
Muscle length   Pearson correlation 
                         Sig. (2-tailed) 
                         N 
1 
 
60 
0.119 
0.364 
60 
MEP       Pearson correlation 
                       Sig. (2-tailed) 
                       N 
0.119 
0.364 
60 
1 
 
60 
6.8 Comparison between the length of the muscle and the distance of PEP 
from the origin of the muscle. 
 Comparison between the length of the muscle with the distance of PEP 
from the origin, showed a moderate positive correlation (Figure 17) with Pearson 
Correlation coefficient of 0.518 (Table 21). 
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Table 21: Pearson correlation coefficient between muscle length and PEP 
 Muscle length PEP 
Muscle length   Pearson correlation 
                         Sig. (2-tailed) 
                         N 
1 
 
60 
0.518 
0.000 
60 
PEP                Pearson correlation 
                       Sig. (2-tailed) 
                       N 
0.518 
0.000 
60 
1 
 
60 
 
 
 
 
Figure 17: Scatter plot graph showing the relation between distance of 
proximal entry point from the origin of muscle and the length of the muscle. 
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6.9 Comparison between the distance of DEP from the origin of muscle 
and the length of the muscle 
Comparison between muscle length and distance of DEP from the origin of 
the muscles (Figure 18) showed a moderate positive correlation with a 
Pearson Correlation coefficient of 0.573 (Table 22).  
 
 
Figure 18: Scatter plot graph showing the relationship between 
distance of distal entry point from origin of muscle and length of 
muscle. 
 
  
73 
 
Table 22: Pearson correlation coefficient between muscle length and DEP 
 
6.9 Comparison between the distance between PEP and DEP and the length 
of the muscle 
Comparison between the length of the muscles and the area of distribution 
of the nerve branches (Figure 19) also showed only a weak positive correlation 
with Pearson correlation coefficient ratio of 0.119 (Table 23). 
  
 Muscle length    DEP 
Muscle length   Pearson correlation 
                         Sig. (2-tailed) 
                         N 
1 
 
60 
0.573 
.000 
51 
DEP               Pearson correlation 
                       Sig. (2-tailed) 
                       N 
0.573 
0.000 
51 
1 
 
51 
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Table 23: Pearson correlation coefficient between muscle length and 
distance covered by motor entry points 
 Muscle length DEP_PEP 
Muscle length   Pearson correlation 
                         Sig. (2-tailed) 
                         N 
1 
 
60 
0.119 
0.407 
51 
DEP_PEP       Pearson correlation 
                       Sig. (2-tailed) 
                       N 
0.119 
0.407 
51 
1 
 
51 
 
Figure 19: Scatter plot showing the relationship between the muscle length 
and distance covered by motor entry points. 
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6.11 Comparison between the variables measured between hamstring and 
adductor group of muscles 
The comparison of the various variables measured for hamstring and 
adductor group of muscles is given in Table 24. 
  The length of the adductor group of muscles and hamstring group of 
muscles showed a significant difference of 7.1 (CI=3.5-10.7). But, the number of 
motor entry points of the two groups did not show a significant difference. The 
distance of PEP from the origin of muscle showed a statistically significant 
difference of 7.7 (CI=0.3-2.5). The distance of DEP from the origin of muscles 
also showed a significant difference of 9.9 (CI=8-11.7). The distance between 
PEP and DEP did not show a significant difference. Though the distance of PEP 
and DEP from the origin of the muscles varies with the two groups of muscles, 
the distance over which the motor entry points are distributed remain the same 
irrespective of length, PEP or DEP. 
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Table 24: Table comparing the calculated variables between adductor group 
of muscles of thigh and hamstring muscles 
 
 
Group N Mean 
Std. 
Deviation p-value 
Mean 
diff. 
95 % CI 
Muscle Length Add. 30 32.32 9.143 <0.001 7.1 3.5 – 10.7 
Hams. 30 39.44 2.876    
MEP Add. 30 4.03 3.479 0.122 1.1 0.3-2.5 
Hams. 30 2.93 1.552    
PEP Add. 30 9.9800 3.18849 <0.001 7.7 5.6 – 9.8 
Hams. 30 17.6567 4.73976    
DEP Add. 23 12.7391 3.17272 <0.001 9.9 8 -11.7 
Hams. 28 22.6036 3.41451    
DEP_PEP Add. 
23 3.3826 2.93763 0.102 1.6 
 0.32 – 
3.4 
Hams. 28 4.9357 3.58951    
DEP_PEP 
_Dist 
Add. 23 4.2286 4.06424 0.449 0.8 1.3- 3 
Hams. 28 5.0546 3.65580    
 
6.12 Comparison of number of motor entry points and ideal localizing 
points for motor point procedures  
We compared the average number of motor entry points per muscle, the position 
of PEP and DEP, and our recommended site of motor point procedures between 
the different muscles studied. The results are tabulated in Table 25.  
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Table 25 - Showing the number of motor entry points, PEP%, DEP% and 
the ideal site for motor point procedures. 
 
Name of muscle Median 
no. of 
MEP’s 
PEP% 
=(PEP/L)X100 
DEP% 
=(DEP/L)X100 
Ideal site for 
motor point 
procedures 
Long head of 
Biceps femoris 
3 35% 51% In the second-
fifth and third-
fifth of the 
muscle length 
(or middle 
1/3
rd
). 
Semitendinosus 2 44% 48% In the third-fifth 
of the muscle 
length (or 
middle 1/3
rd
). 
Semimembranosus 3 53% 70% In the third-fifth 
and fourth-fifth 
of the muscle 
length (or 
middle 1/3
rd
). 
Adductor longus 2 40% 50% In the third-fifth 
of the muscle 
length (or 
middle 1/3
rd
). 
Adductor magnus 1 31% 38% In the second-
fifth of the 
muscle length. 
Gracilis 6 29% 37% In the 2/5
th
 of 
the muscle 
length. 
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Number of MEPs 
In the hamstring group of muscles, the median number of MEPs was 2-3. 
In the adductor group, Gracilis had the maximum number of MEPs of six and 
Adductor magnus had the least number of one.   
Ideal site for motor point procedures 
 The hamstring group of muscles showed maximum number of motor 
entry points in the third-fifth of the muscle length from its origin. The long head 
of Biceps femoris had motor entry points in the second-fifth of the muscle length 
also. The Semimembranosus showed additional motor entry points in the fourth-
fifth of the muscle length also. 
 In the adductor group of muscles, Adductor magnus and Gracilis had 
maximum number of motor entry points in the second-fifth of the muscle length 
from its origin. Adductor longus had all its motor entry points in the third-fifth of 
the muscle length from its origin. 
 Hence, all the invasive interventional procedures for the treatment of 
spasticity like motor point injections and selective motor fasciculotomy must be 
performed at the above mentioned sites for maximum outcome.   
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7. DISCUSSION 
 Precise localization of the motor entry points is essential for the treatment 
of muscle spasticity during procedures like botulinum toxin injection and 
selective motor fasciculotomy (3, 44).  Botulinum toxin acts pre-synaptically by 
blocking the release of acetylcholine (5). This results in chemical denervation of 
the muscle and prevents further muscle contraction (3). Borodic et al., in his 
study on albino rabbits have noted that the botulinum toxin can diffuse only up to 
a distance of 4.5 cm along the length of a  muscle fibre from the site of injection 
(45). In muscles of the lower limb which have a considerable length, diffusion of 
the toxin along the muscle to reach the other end of the muscle is unlikely. 
Multiple injections can deliver the botulinum toxin to a larger region. However, 
there are disadvantages of multiple injections. The toxin can spread to areas 
which lack neuromuscular junctions and also to adjacent tissues and blood 
vessels, leading to complications (41). The botulinum toxin can also diffuse 
across fascia covering the muscles. The spread of botulinum toxin to unwanted 
sites can be prevented by delivering small doses of botulinum toxin to the target 
motor end plate (46). Previously, neuromuscular junctions were thought to be 
located in the middle third of the muscle. But, its position is inconsistent in most 
of the cases (5). In, selective motor fasciculotomy for the treatment of spasticity, 
nerve fibres carrying an excess of impulses to the affected muscles are ablated. 
The procedure is undertaken when the subject is resistant to non-ablative 
procedures (21). It was mostly performed  for the treatment of lower limb 
spasticity, with limited use for upper limb spasticity due to the presence of more 
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complex spastic deformities (20). The results of this study have elucidated in a 
detailed manner, the motor entry points of hamstring muscles and adductor 
muscles of thigh. 
 The posterior femoral muscles are collectively termed the ‘hamstrings’. 
Hamstrings include Biceps femoris, Semitendinosus and Semimembranosus. 
They cause extension of the hip joint and flexion at the knee joint. The muscles 
of the medial or adductor compartment of the thigh are collectively called the 
adductors of thigh. The latter include Gracilis, Pectineus, Adductor longus, 
Adductor brevis and Adductor magnus (13). Out of these, we dissected and 
studied long head of Biceps femoris, Semitendinosus, Semimembranosus, 
Adductor longus, Adductor magnus and Gracilis. 
 
7.1 Long head of Biceps Femoris 
7.11 Number of motor entry points 
In our study, 40 % of long head of Biceps femoris muscles had three 
motor entry points, 30% had two motor entry points and another 30% had four 
motor entry points. In a study done by Seidel et al., (26) in 30 cadaveric lower 
limbs in U.S.A., 70 % of the long head of Biceps femoris had two motor entry 
points and 30 % had three motor entry points. A study done by Botter et al., (37) 
by electric stimulation with surface electrode, revealed the presence of two motor 
entry points for long head of Biceps femoris. 
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7.12 Proximal and Distal motor entry points 
There is scarcity of data in literature regarding the position of PEP and 
DEP in relation to the ischial tuberosity. In our study, the distance of PEP from 
the origin of the muscle was found to be 15 cm which was at 35 % of the muscle 
length and DEP was found to be at 20.7 cm from the origin of the muscle (ischial 
tuberosity) which was at 51 % of the muscle length. Most of the entry points 
were located in the second-fifth and third-fifth of the length of the muscle. So, 
we recommend that the injection of botulinum toxin or selective fasciculotomy 
should be performed at that distance for maximum outcome.  
 In the study done by Seidel et al. (26), PEP was at 9.2 cm from the ischial 
tuberosity and DEP was at 19.7 cm from the ischial tuberosity. The book on 
treatment of spasticity with botulinum toxin by Fheodoroff describes the 
botulinum injection to be given at a point distal to proximal third of the line 
joining ischial tuberosity and medial end of popliteal fossa (38). According to a 
study done by Campenhout (41) in U.S.A., the PEP was located 9.2 cm from 
ischial tuberosity and DEP at 19.7 cm from ischial tuberosity. The optimal 
injection for the long head of the biceps femoris described by Campenhout was 
injection at 25% of the length of the thigh (measured from the superomedial 
aspect of ischial tuberosity to the medial femoral condyle) and one injection 
around 50%.  
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7.13 X and Y conjugates 
In the study done by An et al. (25), the PEP and DEP was not described 
along the length of the muscle. It was described in relation to the X and Y-axis. 
This method of localising MEPs would be clinically impractical because 
localization of the ends of the axes at the greater trochanter and medial femoral 
condyle are not accurately reproducible. 
The X-axis and Y-axis used in the study done by An et al. (25), was a line 
connecting ischial tuberosity to greater trochanter and a line joining ischial 
tuberosity to the medial femoral condyle respectively. In our study the X-axis 
was a line passing through the joint line of knee joint and Y-axis was a vertical 
line dropped perpendicular to the X-axis from the ischial tuberosity. Accurate 
localization of the ends of these axes was reproducible and would be more 
feasible in order to localize the motor points clinically. In our study, most of the 
PEPs could be located at a point 2.4 cm from the Y-axis and 20.8 cm from X-
axis and DEPs could be located at a point 2.3 cm from Y-axis and 13.7 cm from 
X-axis.  
7.2 Semitendinosus 
7.21 Number of motor entry points 
 In our study, 60% of the Semitendinosus muscles had two motor entry 
points, 20% had one and another 20% had three motor entry points. A study done 
by Botter et al., (37) by electric stimulation with a surface electrode, revealed the 
presence of one motor entry point for Semitendinosus muscle. In the study done 
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by Seidel et al., (26) in 30 cadaveric lower limbs in U.S.A., 77% of 
Semitendinosus had two motor entry points while 23% had one motor entry 
point. 
7.22. Proximal and distal entry points 
In our study, the proximal entry point was at 17.5 cm from the origin of 
the muscle which was at 44% of the muscle length. The distal entry point was at 
20.5 cm from the origin of the muscle which was at 48% of the muscle length. 
This distance is within the third-fifth of the muscle length. So, we infer from our 
study that motor point procedures should be focussed in the third-fifth of the 
muscle length from its origin. 
 In the study done by Seidel et al., PEP was at 9 cm from the ischial 
tuberosity and DEP at 19 cm from the ischial tuberosity (26). The book on the 
injection of botulinum toxin by Fheodoroff describes the ideal point of motor 
point injection to be at the middle or distal third of the line joining ischial 
tuberosity to pes anserinus (38). In the book on the treatment of spasticity by 
Berweck et al., the ideal point of botulinum toxin injection was described as 
halfway or two-third up the thigh(40). According to Campenhout (41), the PEP is 
located between 4.2 and 12.2 cm from the ischial tuberosity. The DEP is located 
between 7.5cm and 19 cm from the ischial tuberosity. Campenhout described the 
optimal site of motor point injection of Semitendinosus muscle as 21% - 50% of 
the femur length, along a line joining ischial tuberosity to lateral femoral 
condyle. According to Woodley et al., the PEP of Semitendinosus lies at a 
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distance of 4.2 - 12.2cm from the ischial tuberosity and DEP lies at a distance of 
7.5 - 19cm from the ischial tuberosity (39).  
7.23 X and Y conjugates  
 The X-axis and Y-axis used in the study done by An et al. (25) to describe 
PEP and DEP, was a line connecting ischial tuberosity to greater trochanter and a 
line joining ischial tuberosity to the medial femoral condyle respectively. In our 
study the X-axis was a line passing through the joint line of knee joint and Y-
axis was a vertical line dropped perpendicular to the X-axis from the ischial 
tuberosity. Accurate localization of the ends of these axes was reproducible and 
would be more feasible in order to localize the motor points clinically. Most of 
the PEPs could be located at a point 1.5 cm from Y-axis and 17.5 cm from X-
axis. DEPs could be located at a point 0.2 cm from Y-axis and 14.7 cm from X-
axis. 
 An et al. (25) divided the Semitendinosus into two zones: upper and 
lower. Upper zone was located where the proximal motor nerve branches enter 
the muscle and lower zone, where the distal motor nerve branches enter the 
muscle. In cases where the Semitendinosus muscle had only one motor nerve, the 
latter divided into two branches before entering the muscle. The point of entry of 
the first branch is the upper zone and the point of entry of the second branch is 
the lower zone. In our present study, we could not arrive at two zones because 
PEP and DEP was located close to each other. 
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7.3. Semimembranosus 
7.31. Number of motor entry points  
 In our study, the 40% of Semimembranosus muscle had two motor entry 
points, 30% had three motor points and rest had 4 - 5 motor entry points. The 
study done by An et al., in South Korea, showed the presence of a single motor 
nerve for Semimembranosus muscle. Though it had only one motor nerve, it 
divided into 2-5 branches (average=3.4) before entering the muscle. That is, the 
motor entry points ranged from 2 - 5 in number (25). A study done by Botter et 
al., by electric stimulation with a surface electrode, revealed the presence of one 
motor entry point for Semimembranosus muscle (37). In a study done by Seidel 
et al., 47% of Semimembranosus muscle had five motor entry points, 20% had 
six motor entry points and 33% had 3 - 4 motor points (26).  
7.32. Proximal and distal motor entry points 
In our study, the PEPs of Semimembranosus muscle were located at a 
distance of 19.9 cm from the origin of the muscle, which was at 52.5 % of the 
muscle length. The distance of DEP from the origin of Semimembranosus was 
25.3 cm, which was at 70.1 % of the muscle length. Thus, all the motor entry 
points were located in the third-fifth and fourth-fifth of the muscle length. So, we 
recommend performing motor point procedures on the Semimembranosus 
muscle within third-fifth and fourth-fifth of the muscle length from the origin. 
The motor points were described as percentage length of femur length in 
the study done by Seidel et al. In the same study, 50 % of MEPs of 
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Semimembranosus were located at 25-30 cm from the ischial tuberosity along a 
line drawn to medial femoral condyle (26). According to the study done by 
Campenhout (41), PEP of the Semimembranosus muscle can be located at 14.6 
to 21.2 cm distal to the ischial tuberosity. The DEP of the muscle was at 34.5cm 
distal to the tuberosity. The optimal injection site for the semimembranosus 
muscle described by Campenhout seems to be between 64% and 77% of the 
femur length along a reference line from the ischial tuberosity to lateral femoral 
condyle. In textbooks by Fheodoroff and Berwick, the sites of injection to 
Semimembranosus muscle are described as medial or lateral to Semitendinosus, 
at the limit of middle and distal third of the thigh, or half-way or two-thirds up 
the thigh (38, 40). According to Woodley et al., the PEPs to Semimembranosus 
muscle are located at 14.6 – 21.2cm from the ischial tuberosity and DEPs are 
located at 34.5 cm distal to ischial tuberosity (39). According to another study 
the DEPs of Semimembranosus muscle are more distal than those of the 
Semitendinosus muscle (41).  
7.33 X and Y conjugates 
The X-axis and Y-axis to localize the motor entry points used in the study 
done by An et al. (25), was a line connecting ischial tuberosity to greater 
trochanter and a line joining ischial tuberosity to the medial femoral condyle 
respectively. In our study the X-axis was a line passing through the joint line of 
knee joint and Y-axis was a vertical line dropped perpendicular to the X-axis 
from the ischial tuberosity. Accurate localization of the ends of these axes was 
reproducible and would be more feasible in order to localize the motor points 
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clinically. PEP of Semimembranosus can be located at a point 0.5 cm from Y-
axis and 16.5 cm from X-axis. DEP of Semimembranosus can be located at a 
point 0.4 cm from Y-axis and 10.6 cm from X-axis. 
 The disparities in the different innervations patterns of the hamstring 
muscles may be attributable to anthropometric and racial differences, but they 
may also be related to the different methodologies and measurement methods 
(25). 
7.4. Adductor longus 
7.41. Number of motor entry points  
 There is scarcity of data regarding the number of motor entry points of 
adductor muscles of thigh. In our study, 80% of the Adductor longus muscle had 
two motor entry points and the rest had 6 - 8 motor entry points.  
7.42. Proximal and distal motor entry points 
In our study, the median distance of PEP from the origin of Adductor 
longus was 8.8 cm, which was at 39.3 % of the muscle length. The median 
distance of DEP from the origin of Adductor longus was 9.6 cm, which was at 
49.3 % of the muscle length. All the motor entry points to the Adductor longus 
were concentrated in an area which was 2.5 cm from the PEP or 10.7 % of 
muscle length from PEP, which was within third-fifth of the muscle length. So, 
we suggest the motor point procedures of Adductor longus muscle to be done 
within third-fifth of the muscle length from its origin. 
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 According to the study done by Sung-Yoon Won et al., obturator nerve in 
Adductor longus spreads over a distance between 17.4% and 76.5% along the 
length of the muscle. He also described the region of maximum density of 
neuromuscular junctions in adductor longus muscle at 35 - 50% from anterior 
superior iliac spine and 20 - 40% from adductor tubercle. The ideal injection 
points described by Fheodoroff and Berwick for Adductor longus muscle was in 
proximal third of the thigh (38, 40). According to Campenhout et al., the 
optimum point for motor point injections is distal to 31% of the reference line 
joining pubic tubercle to the medial femoral condyle. In a study done by Kwon et 
al. (47), the motor entry points of Adductor longus muscle of thigh was located 
at 26 ± 4.8 % along a longitudinal axis drawn from the pubic tubercle to medial 
femoral condyle. In a study done by Crystal et al. (48), the mean motor points of 
the Adductor longus muscle was described at 31±1.1 %  along a reference line 
from the symphysis pubis to the medial joint line at the distal extent of the 
medial femoral condyle.  
7.5. Adductor magnus 
7.51. Number of motor entry points 
There is scarcity of data regarding the number of motor entry points of 
Adductor magnus. In our study, the Adductor magnus muscle had a median 
number of motor entry point of one.  
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7.52. Proximal and distal motor entry points 
The median distance of PEP from the origin of Adductor magnus muscle 
was 10.5 cm, which was at 31.2 % of the muscle length. The median distance of 
DEP from the origin of Adductor magnus was 13 cm, which was at 38.2 % of the 
muscle length. All the motor entry points to the Adductor magnus were 
concentrated in an area which was 3.5 cm from the PEP or 10.3 % of muscle 
length from PEP, which was within second-fifth of the muscle length. So, we 
suggest that the motor point injections and selective fasciculotomy should be 
focussed within second-fifth of the muscle length. 
 The ideal injection point of botulinum toxin as described by Fheodoroff 
and Berwick for Adductor magnus is with the patient in a side-lying position, 
anterior and posterior to Grailis in the middle third of the thigh (38,40). 
According to Campenhout et al. (41), the ideal site of injection to Adductor 
magnus was distal to 38% of the reference line joining pubic tubercle to the 
medial femoral condyle. This was at the middle third of the thigh. In a study 
done by Kwon et al. (47), the motor entry points of Adductor magnus was 
located at 30.4 ± 4.1% along a longitudinal axis drawn from the pubic tubercle to 
medial femoral condyle. In a study done by Crystal et al. (48), the mean motor 
points of Adductor magnus were described at a point 38 ± 2.5% of a reference 
line from the symphysis pubis to the medial joint line at the distal extent of the 
medial femoral condyle.  
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7.6. Gracilis 
7.61. Number of motor entry points 
There is scarcity of data regarding the number of motor entry points of 
Gracilis muscle. The Gracilis muscle had a median number of motor entry points 
of six in our study.  
7.62. Proximal and distal motor entry points 
The median distance of PEP from the origin of Gracilis was 12 cm, which 
was at 28.8% of the muscle length. The median distance of DEP from the origin 
of Gracilis was 15.5 cm, which was at 36.7 % of the muscle length. All the motor 
entry points to the Gracilis were concentrated in an area which was 2.8 cm from 
the PEP or 6.5% of muscle length from PEP, which was within second-fifth of 
the muscle length. So, we suggest that the motor point procedures on Gracilis 
muscle should be done within second-fifth of the muscle length from its origin. 
Fheodoroff suggested the ideal point of botulinum toxin injection for 
Gracilis to be at the middle third of a line joining pubic symphysis and pes 
anserinus (38). Berwick suggested the ideal point at the proximal third of the line 
joining pubic symphysis and pes anserinus (40). According to Campenhout et al. 
(41), the optimum points for injection of Gracilis were at the junctions of 
proximal and middle third, and middle and distal third of the thigh. According to 
the study done by Sung-Yoon Won et al., obturator nerve in Gracilis, spreads 
over 17.8% to 86% of the length of the muscle. The region with maximum 
density of neuromuscular junctions was found to be at 29.2 - 33.5% along the 
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length of Gracilis according to Yoon Won et al. This was located 40-50% from 
the anterior superior iliac spine and 25-35% from the pubic tubercle respectively 
(4). In a study done by Kwon et al. (47), the motor entry points of Gracilis was 
located at a point 32.1 ± 2.1% along a longitudinal axis drawn from the pubic 
tubercle to medial femoral condyle. In a study done by Crystal et al. (48), The 
mean motor points of Gracilis were described at 44 ± 3.1% of a reference line 
from the symphysis pubis to the medial joint line at the distal extent of the 
medial femoral condyle.  
7.7 Comparing the number of motor entry points and the length of different 
muscles 
 In our study, the number of motor entry points and the length of muscles 
showed only a weak positive correlation. So, the number of motor entry points is 
almost constant irrespective of the length of the muscle. 
7.8 Comparing the distance of PEP and DEP from the origin of muscle with 
the length of different muscles 
 The distance of PEP and DEP from the origin of the muscle showed a 
moderate positive correlation with the length of the muscle. As the length of the 
muscle increase, the distance of PEP and DEP from the origin of the muscle also 
increases. 
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7.9 Comparing the difference in distance between PEP and DEP with the 
length of different muscles 
 The distance between PEP and DEP showed only a weak positive 
correlation with the length of the muscle. The distance over which all the motor 
entry points are distributed remained almost constant irrespective of the length of 
the muscle. 
7.10. Comparison of ideal injection sites suggested by different authors 
 Different studies have suggested different sites for botulinum toxin 
injection according to the different reference lines and different measurement 
methods used as shown in Table no. 26. 
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Table 26: Table comparing the optimum site for botulinum toxin injection. 
Muscle Present 
study 
Fheodoroff  
et al. 
Berwick et al. Campenhout et 
al. 
Long head of Biceps 
femoris 
35%-50% of 
muscle 
length  
Point distal to 
proximal third of 
line joining 
ischial tuberosity 
and medial end of 
popliteal fossa 
One point at 
25% and 
another point 
at 50% of 
length of 
thigh. 
Not explained. 
Semitendinosus 44%-48% of 
muscle 
length  
Middle or distal 
third of line 
joining ischial 
tuberosity to pes 
anserinus.  
21-50% of 
femur length. 
Half to two-third 
up the thigh. 
Semimembranosus 53-70% of 
muscle 
length  
Medial or lateral 
to semitendinosus 
at limit of middle 
and distal third of 
the thigh. 
64-77% of 
femur length. 
Half way or 
two-thirds up 
the thigh. 
Adductor longus 40-50% of 
muscle 
length  
Proximal 1/3
rd
 of 
thigh. 
31% of the 
reference line 
joining pubic 
tubercle to 
medial 
femoral 
condyle. 
Proximal third 
of the thigh. 
Adductor magnus 31-38% of 
muscle 
length 
In side-lying 
position, anterior 
and posterior to 
Gracilis in middle 
third of thigh. 
Point just 
distal to 38% 
of reference 
line joining 
pubic tubercle 
to medial 
femoral 
condyle. 
In side-lying 
position, 
anterior and 
posterior to 
Gracilis in 
middle third of 
thigh. 
Gracilis 29-37% of 
muscle 
length  
Middle third of 
line joining pubic 
symphysis and 
pes anserinus. 
Limit of 
proximal & 
middle third 
and middle & 
distal third of 
thigh. 
Proximal third 
of line joining 
pubic symphysis 
and pes 
anserinus. 
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7.71. Long head of Biceps femoris 
 The ideal injection site we suggest from our study is between 35% and 
51% of muscle length (Figure 20) or within second-fifth and third-fifth of the 
muscle length. Fheodoroff et al. has suggested a point just distal to proximal 
third of line joining ischial tuberosity and medial end of popliteal fossa (38). 
According to Campenhout, the optimum site of botulinum injection is one at 
25% and another at 50% of the length of the thigh (from superomedial aspect of 
ischial tuberosity to medial femoral condyle) (41). 
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7.72. Semitendinosus 
The ideal site for injection of botulinum toxin in semitendinosus muscle 
suggested by our study is between 44% and 48% of muscle length (Figure 21)or 
within third-fifth of the muscle length. According to Fheodoroff et al., the 
optimum site of injection of botulinum toxin is between middle and distal third 
of the line joining ischial tuberosity to pes anserinus (38). Campenhout et al. 
suggested the optimum injection site as between 21% and 50% of the femur 
length (ischial tuberosity to lateral femoral condyle) (31). According to Berwick 
et al. it is half to two-third way up the thigh (40).  
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7.73. Semimembranosus 
 The optimum site of injection of botulinum toxin suggested from our 
study is between 53% and 70% of the length of semimembranosus (Figure 22) or 
within third-fifth and fourth-fifth of muscle length. Fheodoroff et al. suggested a 
point medial or lateral to semitendinosus muscle at the junction of the middle 
and distal third of the thigh (32). Campenhout et al. suggested the optimum point 
of injection between 64% and 77% of femur length (ischial tuberosity to lateral 
femoral condyle) (31). According to Berweck et al. the ideal site of injection is 
half way or two-thirds up the thigh (33). 
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7.74. Adductor longus 
According to our study, the ideal site for injection of botulinum toxin in 
adductor longus muscle is between 40% and 50% of muscle length (Figure 23) 
or within third-fifth of muscle length. According to Fheodoroff et al. and 
Berweck et al., it is located in the proximal 1/3
rd
 of thigh (32, 33). Campenhout 
et al. suggested a point at 31% of the reference line joining pubic tubercle to 
medial femoral condyle (31). 
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7.75. Adductor magnus 
 The ideal site for botulinum toxin injection of adductor magnus as 
suggested by our study is between 31% and 38% of muscle length (Figure 24) or 
within second-fifth of muscle length. Fheodoroff et al. and Berweck et al., 
suggested a point with the patient in side-lying position, anterior and posterior to 
gracilis in the middle third of the thigh (32, 33). Campenhout et al. suggested a 
point distal to 38% of a reference line joining pubic tubercle to medial femoral 
condyle (31).  
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7.76. Gracilis 
The optimal site for botulium toxin injection in Gracilis muscle as 
suggested by our study is between 29% and 37% of the muscle length (Figure 
25) or within second-fifth of the muscle length. Fheodoroff et al. suggested a 
point at middle third of the thigh joining pubic symphysis and pes anserinus (32). 
According to Campenhout, the ideal sites are at the junctions of the proximal and 
middle third and middle and distal third of thigh (31). Whereas Berweck et al. 
suggested a point at the proximal third of the line joining pubic symphysis and 
pes anserinus (33).  
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8. CONCLUSIONS 
The following were the important conclusions drawn from the study: 
1. All muscles were supplied by motor nerves from the deep aspect of the 
muscle. 
2. Among the adductor group of muscles, Gracilis has the maximum number 
of motor entry points (median = 6) and Adductor magnus has the least 
number (median = 1).  
3. All muscles of the hamstring group had an almost equal number of motor 
entry points (median = 2-3). 
4.  Length of muscle has only a weak positive correlation to the number of 
motor entry points of that muscle, i.e. as the length of the muscle 
increases, the number of motor entry points do not necessarily increase. 
5. The position of PEP in every individual muscle of the hamstring group 
was consistently at the second-fifth of the length of the muscle from 
origin to insertion. 
6. The position of DEP in most individual muscles of the hamstring group 
was consistently at the third-fifth of the length of the muscle from origin 
to insertion. 
7. As per the above findings of our study, the optimum site for invasive 
interventional procedures such as motor point injection of chemical 
neurolytic agents and selective motor fasciculotomy for relief of muscle 
spasticity in the hamstring group should be in the second and third-fifth of 
the muscle length from its origin to insertion. 
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8. All motor entry points of Adductor longus are located between 40% and 
49% of the muscle length, which is within third-fifth of the muscle length. 
9. All motor entry points of Adductor magnus are located between 31% and 
38% of the muscle length which is within second-fifth of the muscle 
length. 
10. All the motor entry points of Gracilis are between 29% and 37% of the 
muscle length which is within second-fifth of the muscle length. 
11. All the motor entry points to the long head of Biceps femoris are located 
between 35 % and 50 % of the muscle length from its origin; that is, 
within second-fifth and third-fifth of the muscle length from its origin. 
12. All the motor entry points of the Semitendinosus are located between 44 
% and 48 % of the muscle length which is within third-fifth of the muscle 
length from its origin. 
13. All the motor entry points of the Semimembranosus are located between 
53% and 70 % of the muscle length which is within third-fifth and fourth-
fifth of the muscle length from its origin. 
These areas are the optimum sites for invasive interventional procedures such 
as motor point injection of chemical neurolytic agents and selective motor 
fasciculotomy for relief of muscle spasticity in neuromuscular disorders. 
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9. LIMITATIONS OF THE STUDY  
1. The reference lines used to define the x and y axis was different among 
the various studies. Hence, it was difficult to compare the values of x and 
y conjugates between the studies.  
2. Though the estimated sample size as per the sample size formula was 10, 
more studies may need to be done from the Indian population to further 
extrapolate the results of this study.  
3. Out of 10 limbs done, only two were that of females. So, no conclusions 
could be made regarding any possible sex variation. 
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11. ANNEXURES 
APPROVAL OF INSTITUTIONAL REVIEW BOARD FOR THE STUDY 
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